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Abstract: 
 
The developmental process is carefully controlled by transcriptional and epigenetic 
changes that occur as a zygote transforms into an adult organism.  This process can be 
reversed by the overexpression of transcription factors Oct4, Sox2, Klf4, and c-Myc, 
which reprogram a differentiated cell!s nucleus to one that is transcriptionally and 
epigenetically indistinguishable from an embryonic stem (ES) cell.  However, it is still 
unclear if transcription factors can completely convert the nucleus of a differentiated cell 
into that of a distantly related somatic cell type with complete transcriptional and 
epigenetic reprogramming maintained in the absence of exogenous factor expression.  
To test this idea, we generated doxycyline (dox)-inducible vectors encoding neural stem 
cell-expressed factors.  We found that stable, self-maintaining NSC-like cells could be 
induced under defined growth conditions.  These cells were characterized in the 
absence of exogenous factor induction and were shown to be transcriptionally, 
epigenetically, and functionally similar to endogenous embryonic cortical NSCs.  
Additionally, a cellular system was created for reproducible generation of dox-
independent iNSCs without additional factor transduction.  Our results show that a 
transcriptionally and epigenetically reprogrammed somatic nucleus can be stabilized in 
vitro and provides a tool to study the mechanism of somatic cell conversion. 
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During mammalian development, the totipotent zygote gives rise to all the cell 
types and tissues that form the adult organism.  As development proceeds, this single 
totipotent cell begins to divide and progressively loses its potency.  By the blastocyst 
stage, two distinct cell types have emerged—a compact cluster of pluripotent cells that 
are the precursors to the embryo and the surrounding trophoblasts that form the 
trophectoderm.   The blastocyst is reorganized for embryonic development during 
gastrulation, and the cells are further restricted to one of three germ layers: ectoderm, 
mesoderm, and endoderm.  This differentiation process continues, and increasingly 
specialized cells are generated until terminally differentiated post-mitotic cells are 
created, which do not have the capability to generate progeny.  
Remarkably, the diverse cell types generated during mammalian development 
contain the exact same genome.  This means that cell function and developmental 
potential are governed entirely by cell type-specific regulation of gene products through 
chemical modifications placed on the genome.  These epigenetic modifications and the 
resulting gene expression patterns provide unique signaling cues that maintain a cell!s 
identity and ensure proper progression through development. 
Normal development is a unidirectional process.  However, since the genomes of 
differentiated cells are equivalent, it raises the intriguing possibility that the epigenetic 
modifications maintaining cell identity can be manipulated such that a cell can be 
“converted” or “reprogrammed” to an entirely different type of cell.  Indeed, this has 
been shown convincingly through decades of work on reprogramming differentiated 
cells to pluripotency.  Recently, these studies culminated with the discovery that just 
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four transcription factors (Oct4, Sox2, Klf4, and c-Myc) are sufficient to reprogram the 
nucleus of any adult cell type to a state identical to embryonic stem cells.  These 
induced pluripotent stem (iPS) cells are now valuable tools for studying the pluripotent 
state, understanding the epigenetic regulation of cells, and creating patient-specific 
therapies. 
The surprising discovery that four transcription factors can provoke this dramatic 
cell fate change to pluripotency has led us to wonder if other cell types can be induced 
in a similar manner.  The work in this thesis focuses on changing the epigenetic identity 
of fibroblasts to that of neural stem cells through the forced expression of transcription 
and chromatin-modifying factors.  In order to provide proper context for this work, the 
introduction will discuss three topics: 1) embryonic stem cells and the methods used for 
nuclear reprogramming, 2) neural stem cells and the factors that drive their biology, and 
3) the meaning of “transdifferentiation” and evidence for it in the literature. 
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Part I: Embryonic stem cells and nuclear reprogramming 
 
 
Embryonic stem cells 
The first pluripotent cells to be grown in vitro were embryonal carcinoma (EC) 
cells, derived from mouse germ cell tumors.  Analysis of these transformed cells 
elucidated growth conditions under which pluripotent cells can be grown in vitro (Smith 
and Hooper, 1983; Kahan and Ephrussi, 1970).  Embryonic stem (ES) cells are 
pluripotent cells derived from the inner cell mass (ICM) of pre-implantation blastocyst 
stage embryos.  During in vivo development, the cells in the ICM are a transient cell 
type and differentiate into the epiblast and the hypoblast.  However, unlike the cells of 
the ICM, when explanted in vitro, ES cells can grow indefinitely and maintain the ability 
to differentiate into all of the cell types that make up the embryo (Evans and Kaufman, 
1981; Martin 1981; Thomson et al., 1998). 
 
Key intrinsic and extrinsic factors for ES cells 
The ease with which ES cells are grown in vitro has allowed for careful analysis 
of this cell state and, along with classical genetic approaches, has led to a detailed 
understanding of the intrinsic and extrinsic drivers of pluripotency.  Below are a few of 
the factors known to be important for this process. 
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Oct4/Pou5f1 
Oct4, a POU-domain transcription factor encoded by the Pou5f1 gene, was the 
first transcription factor found to regulate pre-implantation embryo development 
(Okamoto et al., 1990; Rosner et al., 1990; Scholer et al., 1990).  Oct4 expression is 
closely associated with the pluripotent state.  The protein is initially present in the 
developing embryo as a maternally inherited factor (Scholer et al., 1989a), and the 
zygotic gene is expressed throughout early development, including in the blastomere, 
ICM, and epiblast (Yeom et al., 1996).  In the adult, Oct4 expression is restricted to 
primordial germ cells (Pesce and Scholer, 2001; Scholer et al., 1989b).  The Oct4 gene 
is dispensable for all somatic cells (Lengner et al. 2007), but required for early 
embryogenesis; null embryos display peri-implantation lethality, and their ICM lacks 
pluripotent cells (Nichols et al., 1998).  Oct4 expression in ES cells is tightly regulated to 
maintain self-renewal: too much expression triggers differentiation to primitive endoderm 
and mesoderm, and too little expression results in trophectoderm formation (Niwa et al., 
2000).  Interestingly, Oct4 binds regulatory elements with a number of partner factors to 
control gene expression (Scholer et al., 1991; Yuan et al., 1995; Ambrosetti et al., 1997; 
Ben-Shushan et al., 1998; Botquin, et al., 1998). 
 
Sox2 
Sox2 is a well-studied binding partner of Oct4, and the two regulate the Fgf4 
gene through cooperative binding (Kamachi et al., 2000; Yuan et al., 1995; Ambrosetti 
et al., 1997).  Sox2 is a member of the SRY-related HMG-box family of transcription 
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factors.  Like Oct4, it is expressed in the ICM, epiblast, and germ cell, but unlike Oct4 it 
is also expressed in somatic cells.  Sox2 is highly expressed in the multipotent stem and 
progenitor cells in the developing nervous system and extraembryonic ectoderm (Avilion 
et al, 2003; Zappone et al., 2000), as well as numerous adult stem cell compartments 
(Arnold et al., 2011).  Sox2-deficient embryos die during peri-implantation due to defects 
in the epiblast (Avilion et al., 2003).  Furthermore, Sox2 is required for the proper 
expression of Oct4 in mouse ES cells, and Sox2-null ES cells cannot be established 
(Masui et al., 2007). 
 
Nanog 
The Nanog homeodomain transcription factor was initially discovered as a factor 
whose constitutive expression promotes the proliferation of ES cells and the 
maintenance of pluripotency in conditions that otherwise induce differentiation 
(Chambers et al. 2003; Mitsui et al., 2003).  Nanog is critical for pluripotency in vitro and 
in vivo.  Nanog-null ES cells proliferate slower than wild-type ES cells and differentiate 
into extraembryonic endoderm in the absence of cytokine signaling (Mitsui et al., 2003).  
Embryos deficient for Nanog fail to develop epiblast cells and die shortly after 
implantation (Mitsui et al., 2003).  Interestingly, Nanog levels has been reported to 
fluctuate within ES cell colonies, suggesting that it may not be crucial for the 
maintenance of pluripotency, although its down-regulation does predispose ES cells to 
differentiation (Chambers et al., 2007).  Established ES cells in which Nanog is 
genetically deleted maintain the ability to self-renew and contribute to all three germ 
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layers of mouse chimeras (Chambers et al., 2007).  This suggests that Nanog is 
important for the establishment of pluripotency, but is dispensable for maintaining 
pluripotency (Chambers et al., 2007). 
 
Klf4 
Klf4, or Kruppel-like factor 4, is a zinc-finger transcription factor expressed in a 
variety of somatic cell types such as the colon, small intestine, stomach, and skin, 
among others (Shields et al., 1996; Garrett-Sinha et al., 1996).  Prior to the discovery of 
iPS reprogramming (Takahashi and Yamanaka, 2006), only one study had examined 
Klf4!s role in ES cells.  That was a report by Niwa and colleagues showing that Klf4 in 
conjunction with Oct4 and Sox2 activates the Lefty1 gene in ES cells (Nakatake et al., 
2006).  It is now known that Klf4 and its closely related family members Klf2 and Klf4 
play important roles in pluripotency, since the simultaneous knockdown of all three 
results in ES cell differentiation (Jiang et al., 2008). 
 
Lif/Stat3 
Leukemia inhibitory factor (Lif) was first cloned as a cytokine that could induce 
the differentiation of myeloid leukemia cells into macrophages (Gearing et al., 1987).  It 
was later identified as the paracrine factor secreted by fibroblasts that promotes the 
self-renewal of ES cells (Smith et al., 1987; Williams et al., 1988).  Lif is a member of 
the IL-6 cytokine family, and its binding to the Lif receptor (Lif-R) causes 
heterodimerization between the Lif-R and Gp130, which in turn activates the STAT3 
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transcription factor (Ernst et al., 1996).  Klf4 is a downstream target of Lif signaling, and 
it has been shown that forced expression of Klf4 promotes Lif-independent growth of ES 
cells (Niwa et al., 2009). 
 
The core transcriptional circuitry of ES cells 
The key characteristics of ES cells—their self-renewal and pluripotency—are 
maintained by a unique transcriptional circuitry that ensures the expression of ES cell-
associated genes necessary for self-renewal while also maintaining the repression of 
key developmental regulators necessary for differentiation (Figure 1).  Genome-wide 
analysis of transcription factor binding in ES cells has provided insight into how these 
factors act globally to maintain pluripotency.  In ES cells, three transcription factors—
Oct4, Sox2, and Nanog—bind to and regulate their own and each other!s promoter, 
forming a highly redundant interconnected auto-regulatory loop (Loh et al., 2006; Boyer 
et al., 2005) (Figure 1).  This important finding suggests one possible explanation for 
why the ES state is stable: once the auto-regulatory loop is active, it maintains its own 
expression. Furthermore, these key transcription factors may continuously buffer the 
expression of one another, such that variations in one factor!s expression can be 
compensated for by the other factors.  This has been shown to be the case for Oct4 and 
Sox2, where the forced expression of Oct4 can rescue the pluripotency defect of Sox2-
null ES cells (Masui et al., 2007). 
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Figure 1. Transcriptional circuitry of ES cells 
In ES cells, Oct4, Sox2, and Nanog bind to their own and each other!s promoters.  This 
creates a feed-forward auto-regulatory loop that maintains the expression of these 
genes in ES cells.  These transcription factors also bind to many other genes.  At active 
genes, their concerted binding maintains the expression of genes necessary for the ES 
cell state.  Repressed genes are not only bound by Oct4, Sox2, and Nanog, but also by 
the repressive Polycomb Group proteins (PcG).  This binding pattern leaves the genes 
(often developmental regulators) poised for expression upon differentiation cues.  Figure 
adapted from Young, 2011. 
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Another important finding from these genome-wide studies is that Oct4, Sox2, 
and Nanog have coordinated binding on many of their target genes, which include both 
active and inactive genes (Figure 1).  For the active genes, the concerted action of 
these transcription factors acts to reinforce and sustain the unique transcriptional state 
of ES cells by maintaining the expression of ES cell-expressed regulators.  The 
repressed genes are not only bound by the three key transcription factors, but also by 
the Polycomb repressive complex (PRC) 2, which epigenetically marks genes for 
inhibition by trimethylating histone H3 lysine 27 (H2K27me3) (Boyer et al., 2006; Lee et 
al., 2006; Cao et al., 2002).  Interestingly, these repressed genes are developmental 
regulators that are not expressed in ES cells, but “poised” for rapid expression in 
response to developmental cues. (Boyer et al., 2006; Lee et al., 2006).  Indeed, 
disruption of PRC2 in ES cells relieves the repression on poised genes and results in 
their expression (Boyer, 2006).  Thus, the core transcriptional circuitry of ES cells 
maintains the ES cell-specific phenotype by cooperatively binding to and activating 
genes necessary for the ES cell state, while simultaneously keeping repressed genes 
poised for expression upon differentiation (Young, 2011).  
 
Transcription factors and enhancers 
Transcription factors bind DNA at enhancers, where they coordinate with histone 
modifiers, chromatin remodelers, and mediators of transcription to dictate gene 
expression (Buecker and Wysocka, 2012; Spitz and Furlong, 2011).  Since DNA is 
packaged into nucleosomes, some DNA sites are inaccessible to transcription and other 
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factors.  Cooperative transcription factor binding, like that observed for the core ES 
factors (Oct4, Sox2, and Nanog) is one way that factors can overcome this barrier (Calo 
and Wysocka, 2013; Adams and Workman, 1995).  Alternatively, some transcription 
factors have a unique ability to reposition nucleosomes.  These so-called “pioneer” 
factors open enhancer sites so other factors can bind (Calo and Wysocka, 2013; Zaret 
and Carroll, 2011). 
Enhancers are specifically marked throughout the genome.  All enhancers (active 
and poised) are marked by histone 3 lysine 4 mono-methylation (H3K4me1), but active 
enhancers have an additional mark, histone 3 lysine 27 acetylation (H3K27ac) 
(Creyghton et al., 2010; Rada-Iglesias et al., 2011).  Each cell type has a characteristic 
enhancer chromatin pattern, and enhancer profiles change during differentiation 
(Creyghton et al., 2010).  In fact, enhancer usage is so specific that a gene expressed in 
two different cell types can be regulated and marked by different enhancers in the two 
cell types, such as the case of Pou5f1 (which encodes Oct4), which is driven by 
different enhancers in pre- versus post-implantation pluripotent cells (Yeom et al., 
1996). 
 
Nuclear reprogramming 
Epigenetic marks like H3K4me1 or H3K27ac are placed on the genome to 
regulate gene expression and to ensure that proper cell identity is maintained 
throughout development.  Since development is a unidirectional process, it was not 
immediately clear if these marks could be modified such that a cell assumes a different 
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nuclear identity.  We now know that this is possible and that successfully 
reprogramming of a differentiated cell!s nucleus to the pattern present in pluripotent 
cells gives it properties of self-renewal and pluripotency.  This reprogramming event can 
be achieved by three methods: nuclear transfer, cell fusion, and forced transcription 
factor expression (Figure 2). 
 
Nuclear transfer 
During fertilization, the epigenetic marks of the gametes are reprogrammed to 
allow for early embryonic development, a process mediated by the cellular components 
of the oocyte (Morgan et al. 2005).  The first hints that the somatic nucleus can be 
reprogrammed originated from nuclear transfer experiments in Xenopus.  John Gurdon 
showed that proper development can proceed even if the nucleus of an egg is replaced 
by the differentiated nucleus of a tadpole intestinal cell (Jaenisch, 2012; Gurdon, 1960).  
This demonstrated that all cells have the requisite genetic information for full 
development. 
The cloning of "Dolly the Sheep! demonstrated that nuclear transfer can be 
applied to more complex developmental systems (Wilmut et al., 1997).  However, 
nuclear transfer/ reproductive cloning was found to be extremely inefficient: most 
embryos die soon after implantation, and many of the surviving ones are born 
developmentally abnormal, likely due to incomplete epigenetic reprogramming  
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Figure 2. Nuclear reprogramming techniques.   
There are three main methods to reprogram somatic cells to pluripotency.  Nuclear 
transfer involves removing the nucleus of an oocyte and replacing it with a somatic 
nucleus.  The factors in the oocyte are sufficient to induce pluripotency (Left).  ES cells 
have dominant trans-acting factors that can impart pluripotency of a somatic nucleus 
upon cellular fusion (Middle).  The overexpression of 4 transcription factors (Oct4, Sox2, 
Klf4 and c-Myc) in somatic cells can reprogram their nucleus to pluripotency (Right).   
Figure adapted from Jaenisch and Young, 2008. 
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(Hochedlinger and Jaenisch, 2006).  Despite this, the nuclear transfer technology 
provided unequivocal proof that terminally differentiated cells have the capacity to be 
reprogrammed to pluripotency (Hochedlinger and Jaenisch, 2002; Eggan et al., 2004). 
Despite the therapeutic potential and biological importance of the nuclear 
transfer-mediated reprogramming, this technique has some major drawbacks that have 
limited its widespread use.  Chief among these are the limited supply of oocytes and 
ethical concerns of using human oocytes for this process.  Additionally, nuclear transfer 
has proven to be a technically difficult process in the mammalian system—with success 
in the human occurring nearly 55 years after Gurdon!s initial discovery (Tachibana et al., 
2013). 
 
Cell fusion 
Cell fusion mixes two cells! cellular components and allows the dominant trans-
acting factors of one cell to exert control over gene expression in the other cell, inducing 
genes that would otherwise not be expressed.  In this way, the resulting hybrid!s 
phenotype is generally associated with the cell that expressed the most dominant acting 
factors (Graf, 2011).  This has been shown to be the case for pluripotent cells, such as 
embryonal carcinoma cells and embryonic stem cells (Miller and Ruddle, 1976; Tada et 
al., 2001; Cowan, 2005).   
Cell fusion has demonstrated that ES cells, like oocytes, have trans-acting 
factors that can bestow pluripotency on a differentiated nucleus.  Unfortunately, the 
nature of the fusion event makes it extremely difficult to separate the nuclei and recover 
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diploid cells.  For this reason, cell fusion has limited applicability for patient-specific 
therapy or studies on the mechanisms of nuclear reprogramming 
 
Factor-mediated reprogramming 
The concepts of nuclear reprogramming took a dramatic leap forward with 
Takahashi and Yamanaka!s discovery that four transcription factors are sufficient to 
initiate a cascade of cellular changes that results in a pluripotent, epigenetically 
reprogrammed nucleus (Takahashi and Yamanaka, 2006).  Reprogramming quickly 
went from being an inefficient, technically-cumbersome phenomenon mediated by 
obscure factors present in oocytes or ES cells, to a highly reproducible, widely-
applicable process mediated by the overexpression of four proteins—Oct4, Sox2, Klf4, 
and c-Myc.  Although the induced pluripotent stem (iPS) cells initially reported were not 
competent for germline transmission, a hallmark of pluripotent cells, this was later 
shown to be an artifact of the gene used for iPS selection and not a deficiency in the 
reprogramming mechanism itself (Maherali et al., 2007; Okita et al., 2007; Wernig et al., 
2007).  In fact, iPS cells have been shown to fulfill even the most stringent test of 
pluripotentcy—tetraploid complementation (Zhao et al., 2009).   
Many iPS cells have complete epigenetic reprogramming, including the full 
complement of histone marks and enhancer sites, although vestiges of epigenetic 
memory remain in some clones (Creyghton et al., 2010; Kim et al., 2010).  Although 
highly reproducible, the generation of fully reprogrammed cells is quite slow and 
inefficient with just ~0.001-0.1% of transduced cells attaining pluripotency after 3-4 
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weeks (Wernig et al., 2007, Wernig et al., 2008a).  Importantly, iPS reprogramming has 
been shown to epigenetically reprogram terminally differentiated cells, demonstrating 
that this process works for all cell types tested (Hanna et al., 2008; Wernig et al., 
2008b). 
The mechanism by which the four factors induce pluripotency currently is an 
intensely studied process.  The analysis of this process has been greatly aided by the 
establishment of a "secondary! reprogramming system (Hanna et al., 2008; Wernig et 
al., 2008a).  In this system (Figure 3), doxycyline (dox)-inducible vectors are used to 
express the four factors, and fully reprogrammed iPS cells are generated.  When the 
iPS cells are injected into a blastocyst for chimera formation, the iPS cells give rise to 
cells in the chimera tissue with the exact transgene integration pattern as the original 
("primary!) iPS cells.  Then, addition of dox to the culture can produce "secondary! iPS 
cells.  Thus, it is a reprogramming system in which genetically homogenous embryonic 
or adult cells can be reprogrammed without the need for factor transduction. 
The secondary reprogramming system has led to multiple important findings 
about factor-mediated reprogramming.  First, it has aided in the reprogramming of 
terminally differentiated B-cells by circumventing the need for factor transduction, thus 
increasing the efficiency of the process (Hanna et al., 2008).  Second, it has allowed for 
a careful analysis of reprogramming kinetics, which resulted in the discovery that given 
unlimited time, all cells will reprogram; the perceived low efficiency stems from analysis  
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Figure 3. The secondary reprogramming system.   
Doxycyline (dox)-inducible lentiviruses are used to express the four factors, and fully 
reprogrammed iPS cells are generated.  When the iPS cells are injected into a 
blastocyst for chimera formation, the iPS cells give rise to cells in the chimera with the 
exact factor integrations as the original ("primary!) iPS cells.  After selection these cells 
can be reprogrammed with dox induction alone to generate "secondary! iPS cells.  
Figure adopted from Wernig et al., 2008a. 
 
 28!
at relatively early time points (Hanna et al., 2009).  Third, it makes possible the study of 
the reprogramming process in genetically identical single cells, thus minimizing 
differences caused by variable transgene transductions. 
 
Is the pluripotent state uniquely amenable to reprogramming? 
Several lines of evidence suggest that ES cells may be unique in their capacity 
for in vitro nuclear reprogramming.  As described above, cell fusion experiments show 
that ES cells can bestow characteristics of pluripotency on a somatic nucleus after cell 
fusion.  This suggests that ES cells have dominant trans-acting factors that are able to 
override somatic cell identity (Tada et al., 2001).  Pluripotent cells also express 
numerous, well-characterized transcription factors that are known to cooperatively 
regulate genes.  Importantly, these factors bind to their own enhancers and maintain the 
proper expression of each other, thereby forming an endogenous interconnected, 
autoregulatory gene circuit (Boyer et al., 2005) that may maintain the ES cell state once 
it is activated.  Finally, pluripotency may be further stabilized in vitro by its unique 
epigenetic environment.  Experiments on the Moloney murine leukemia virus have 
demonstrated that pluripotent cells express unique epigenetic regulators that methylate 
retroviruses and silence their transcription (Barklis et al., 1986; Jahner et al., 1982).  It 
has also been shown that the transcriptional silencer responsible for this process, 
Trim28, is present in pluripotent cells, but downregulated during differentiation (Wolf and 
Goff, 2007).  Another epigenetic characteristic specific to pluripotent cells is their 
destabilized nucleosome remodeling and histone deacetylation (NuRD) complex, which 
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is due to their low expression of NuRD component Mbd3 (J. Hanna, unpublished data).  
In somatic cells, which express higher levels of Mbd3, the NuRD complex is responsible 
for widespread transcriptional repression (Xue et al., 1998).  Importantly, Mbd3 
expression has recently been shown to be a major barrier for nuclear reprogramming (J. 
Hanna, unpublished data).  Finally, the growth advantage that pluripotent cells have 
over somatic cells and their domed morphology may aid the practicality of detecting rare 
iPS reprogramming events and isolating them for further study.  
 
 
This first section has discussed ES cells and mechanisms that govern their 
characteristic qualities of self-renewal and pluripotency.  A differentiated cell can 
assume these ES cell traits through nuclear reprogramming, such as that achieved by 
the overexpression of Oct4, Sox2, Klf4, and c-Myc.  ES cells have unique properties 
that stabilize their cell state, but it is currently not known if a non-pluripotent cell state 
can also be induced by transcription factor overexpression.  Since neural stem cells 
share self-renewal and multipotency features with ES cells, their cell state may also be 
stabilized in vitro.  
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Part II. Neural Stem Cells 
 
 
The default model of neural induction 
In mammalian development, neural cells originate from the ectoderm germ layer 
during gastrulation.  In addition to the neural cells of the central nervous system (CNS), 
the ectoderm also gives rise to the neural crest (migratory cells that become 
melanocytes, facial cartilage, and the peripheral nervous system) and the epidermis 
(which forms the skin).  Early neural induction experiments performed in amphibian 
model organisms have analyzed how neural cells are specified within the developing 
embryo.  The work of Spemann and Mangold suggested that neural tissue is specifically 
induced by factors originating in the “organizer,” a specific part of the embryo that 
develops into neural tissue.  When presumptive neural tissue, which includes the 
organizer, was transplanted from one salamander embryo to another embryo, the 
recipient embryo developed two complete nervous systems—its normal nervous system 
and a second one at the site of transplantation, which would have otherwise formed the 
epidermis (Hemmati-Brivanlou and Melton, 1997a).  We now know that the signals 
emanating from the organizer are not inducing neural tissue, but rather repressing other 
cell fates by inhibiting Bmp4 signaling (Hemmati-Brivanlou and Melton, 1994a; 
Hemmanti-Brivanlou and Melton, 1994b; Smith et al, 1993).  Thus, in the absence of 
differentiation signals, neural formation is the “default fate” of ectoderm development in 
certain model organisms (Hemmati-Brivanlou and Melton, 1997a, Hemmati-Brivlanou 
and Melton, 1997b).  However, it has since been shown that Bmp4 inhibition is not 
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sufficient for neural induction in higher organisms and that instructive signals, such as 
those provided by fibroblast growth factors, are also required for proper neural 
development (Gaulden and Reiter, 2008; Munoz-Sanjuan and Brivanlou, 2002).  The 
key factors and signaling pathways for mammalian neural development will be 
discussed in more detail below. 
 
Types of neural stem cells 
Neural stem cells (NSCs) are the somatic progenitor cells that give rise to the 
entire mammalian CNS. Like all stem cells, NSCs have the capacity to either self-renew 
or differentiate, and differentiation generates neurons, astrocytes, and oligodendrocytes 
(Gage, 2000).  A number of distinct types of NSCs are generated during CNS formation, 
and many have been isolated from the brain and explanted for analysis in vitro 
(Cattaneo and Mckay, 1990; Reynolds and Weiss, 1992; Doetsch et al., 1999).  The use 
of ES cells has further aided our understanding of this cell type by allowing for the 
generation of many NSC types in vitro that share the properties of their in vivo 
counterparts (Conti and Cattaneo, 2010) (Figure 4).  The following includes a brief 
description of some well-studied types of NSCs. 
 
Neuroepithelial stem cells 
In the developing mouse, the first NSCs are generated during the early stages of 
neurulation.  These neuroepithelial cells (NECs) form a sheet of epithelial-like cells that  
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Figure 4.  NSC subtypes in vivo and in vitro. 
Various types of NSCs are generated during mammalian development.  Shown 
are the NSCs that have been isolated or generated in vitro, along with their 
corresponding developmental stage in vivo and growth factor dependence in 
vitro.  Figure adapted from Conti and Cattaneo, 2010. 
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make up the neural tube and are responsible for the first wave of neurogenesis (Smart, 
1973).  They initially undergo rapid, symmetric cell divisions and later transition to 
asymmetric division, producing both NSCs and cells that migrate radially outward (Conti 
and Cattaneo, 2010).  Mouse ES cells rapidly differentiate to NEC-like cells in the 
absence of serum and cell contact (Smukler et al., 2006; Tropepe, 2001).  The NEC-like  
cells express neural markers like Nestin and Sox1, but also retain many characteristics 
of ES cells such as Oct4 expression, dependence on Lif signaling, and the ability to 
contribute to all the germ layers of mouse chimeras (Smukler et al., 2006; Tropepe, 
2001). 
 
Rosette-stage NSCs 
 Rosette-stage NSCs (R-NSCs) are an ES cell-derived cell type that corresponds 
to NSCs present in vivo at the late-neural plate stage (Elkabetz et al., 2008; Elkabetz 
and Studer, 2008).  These cells are distinguished by their capability to differentiate into 
CNS and PNS fates, characteristic rosette morphology, and dependence on Notch and 
Sonic Hedgehog (SHH) signaling for proliferation (Elkabetz et al., 2008).  Additionally, 
R-NSCs have a distinct gene expression pattern that includes Sox1, FoxG1, PLZF, 
Nestin, ZO-1, and Forse1 expression (Conti and Cattaneo, 2010).  Long-term self-
renewing human ES-derived neuroepithelial stem cells (lt-hESNSCs) are another type of 
rosette-NSC derived from ES cells (Koch et al., 2009).  They display many of the 
properties of R-NSCs including rosette-specific gene expression, broad differentiation 
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capacity, and rosette morphology, but lt-hESNSCs proliferate with EGF and FGF growth 
factors. 
 
Radial glial cells 
During development, radial glial neural stem cells (RGCs) are generated from 
NECs at the onset of neurulation and are the main NSC type in the developing brain 
(Franco and Muller, 2013, Conti and Cattaneo, 2010).  A number of qualities distinguish 
RGCs from NECs: RGCs have fewer epithelial features, which includes the loss of tight 
junctions (Aaku-Saraste et al., 1996); they express astroglial markers not expressed in 
NECs, such as Blbp and Glast (Hartfuss et al., 2001); and they have a more restricted 
differentiation potential, with most being bipotent or unipotent (Conti and Cattaneo, 
2010).  Basal progenitors, also called intermediate progenitor cells, are unipotent 
neuronal stem cells that are generated in vivo from differentiating RGCs or NECs (Conti 
and Cataneo, 2010). 
 
Key intrinsic and extrinsic factors for NSCs 
NSC subtypes display a multitude of characteristics based on the extrinsic factors 
they encounter in their niches, as well as their expression of intrinsic factors that control 
gene expression or modulate the chromatin.  The complex interplay of these factors 
during development gives NSCs their positional and temporal identities, and in vitro they 
determine the cells! developmental potentials.  Many key extrinsic factors have been 
determined by studying the in vitro growth properties of NSCs explanted from the brain, 
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and many intrinsic factors have been elucidated by the genetic analysis of genes that 
have been found to be required for proper NSC function.  Insight into these factors is 
necessary for a full understanding of the mechanisms governing the induction and 
maintenance of this cell type.  The following is a brief description of many such factors. 
 
EGF and bFGF 
Epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) are 
mitogens from the receptor tyrosine kinase (RTK) family that promote the in vitro self-
renewal of multiple types of NSCs, including RGCs of the subventricular zone (SVZ) and 
ES-derived NSCs (Conti and Cattaneo, 2010; Reynolds and Weiss, 1992).  EGF is the 
main contributor to NSC proliferation, since removal of bFGF has little effect on 
proliferation, whereas EGF withdrawal results in slower proliferation and cell death 
(Conti et al., 2005, Pollard et al., 2006).  Furthermore, NSCs derived in bFGF alone 
have a limited growth potential and become restricted to glial progenitors after several 
divisions (Conti et al., 2005).  The importance of these signaling molecules for brain 
development in vivo was confirmed by genetic knockout experiments; mice lacking the 
EGF receptor develop neurodegeneration in the frontal cortex (Sibilia et al., 1998; 
Threadgill et al., 1995) and mice deficient in bFGF have a reduced expansion of the 
progenitor pool during neurogenesis (Raballo et al., 2000). 
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Sonic Hedgehog 
Sonic Hedgehog (SHH) signaling has important roles during limb and neural 
development, and its misexpression can lead to developmental malformations and 
cancer (Chiang et al., 1996, Hahn, et al., 1996).  SHH signaling promotes the 
proliferation and maintenance of embryonic and adult NSCs both in vivo and in vitro 
(Ahn and Joyner, 2005; Palma et al. 2005; Lai et al., 2003).  In addition to its roles in 
NSC proliferation and maintenance, SHH also has an instructive role and can induce 
NSC formation from neural tissue that otherwise does not form NSCs (Scott et al., 
2010). 
 
Wnt/!-catenin 
Multiple members of the Wnt family are expressed in the CNS (Parr et al., 1993), 
and this pathway plays a critical role in NSC proliferation (Chenn and Walsh, 2002).  For 
instance, expression of a stabilized version of "-catenin, the downstream transducer of 
Wnt, results in an enlarged brain due to expansion of the progenitor pool.  The converse 
is also true, where the conditional deletion of "-catenin in the nervous system results in 
a decreased progenitor pool and smaller brain size (Zechner et al., 2003).   
 
Notch and Notch effectors 
Notch is both a receptor and a transcription factor.  After binding to its ligand 
Jagged or Delta-like, Notch is cleaved in its transmembrane domain, and the released 
intracellular domain (ICD) translocates to the nucleus and induces gene transcription 
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(Kopan, 2012). Notch signaling maintains the self-renewal of NSCs, and its deletion in 
NSCs leads to neuronal differentiation and depleted progenitor pools (Shi et al., 2008; 
Yoon and Gaiano, 2005).  A similar phenotype is observed when the redundant Notch 
effectors Hes1, Hes3, and Hes5 are simultaneously knocked-out (Imayoshi et al., 2010, 
Ohtsuka et al., 1999).  Constitutive expression of the Notch ICD leads to sustained 
effector gene expression resulting in forced maintenance of the NSC-state and inhibition 
of neuronal differentiation (Ohtsuka et al., 1999).  Interestingly, Notch is also active in 
the final stages of neural differentiation when it biases multipotent progenitors towards 
an astrocyte fate as opposed to an oligodendrocyte one (Grandbarbe et al., 2003, 
Tanigaki et al., 2001). 
 
Sox1, Sox2, and Sox3 
The SoxB1 family of transcription factors—Sox1, Sox2, and Sox3—are 
expressed in the developing nervous system where they have highly redundant 
functions in the maintenance of NSCs (Bylund et al., 2003; Wood and Episkopou, 
1999).  Sox1 is one of the earliest transcription factors expressed during the induction of 
neuroectoderm (Pevny et al., 1998), and its forced expression in ES cells leads to 
neural differentiation (Pevny et al., 1998).  Sox2 is expressed in ES cells, but becomes 
restricted to the prospective neural plate at the onset of gastrulation (Wood and 
Episkopou, 1999).  Constitutive expression of Sox2 in NSCs inhibits their differentiation 
and maintains NSC characteristics, whereas loss of Sox2 induces differentiation and 
loss of NSC characteristics (Graham et al., 2003).  Like Sox2, Sox3 also promotes the 
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maintenance of NSCs when constitutively expressed, and its inhibition causes 
differentiation (Bylund et al., 2003). 
 
FoxG1 
Forkhead-box G1 (FoxG1) is a transcriptional repressor associated with forebrain 
development (Fasano et al., 2009, Tao et al., 1992).  Misexpression of FoxG1 causes 
mental disorders like Rett syndrome, epilepsy, and microcephaly (Danesin and Houart, 
2012).  FoxG1 dosage is thought to temporally regulate neurogenesis in the developing 
cortex (Danesin and Houart, 2012), with increased expression in the more restricted 
progenitors (Shen et al., 2006).  Bmi1, which is important for the self-renewal of many 
types of somatic stem cells, cooperates with FoxG1 to maintain self-renewal in forebrain 
NSCs (Fasano et al., 2009). 
 
Brn1 and Brn2 
The Brain (Brn) proteins are POU-domain homeobox transcription factors 
expressed specifically in the developing and adult nervous system (He et al., 1989).  
Brn1 and Brn2 are expressed in NSCs and in migrating cortical neurons, and mice 
deficient for both genes display cortical defects (McEvilly et al., 2002; Sugitani et al., 
2002).  Brn2 and Sox2 co-occupy many distal enhancers in NSCs, suggesting that they 
may be partner factors (Lodato et al., 2013). 
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Pax6 
Paired-box gene 6 (Pax6) is a highly conserved transcription factor that is critical 
for the development of the CNS, eyes, and nose (Georgala et al., 2011). In humans, 
mutations in this gene are associated with multiple disorders, most notably aniridia (Ton 
et al., 1991).  Pax6 is expressed in various NSCs and more restricted progenitor cells, 
where mutations affect proliferation, multipotency, and neurogenesis (Sansom et al. 
2009). 
 
Transcriptional regulation of NSCs 
Unlike ES cells, NSCs do not have a well-characterized transcriptional circuitry 
network, and thus little is known about the precise molecular control of the NSC cell 
state.  One hypothesis for NSC maintenance, however, is the dynamic regulation of 
Notch effectors and proneural transcription factors. This regulation is precisely 
controlled in NSCs to strike a delicate balance between NSC self-renewal and 
neurogenesis, and its misregulation often results in developmental disorders and 
cancers (Lasky and Wu, 2005; de Ponual et al., 2003; Molofsky et al., 2005; Molofsky et 
al., 2003).  
As mentioned above, Notch is a transmembrane receptor expressed in NSCs. It 
is activated upon binding its ligand Delta, whose expression in neighboring cells is 
induced by proneural transcription factors (Castro et al., 2006; Henke et al., 2009).  
Upon activation, Notch is cleaved and acts as a transcription factor to induce the 
expression of a number of genes, most notably Hes1 (Figure 5A).  Hes1 is a  
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Figure 5.  Oscillations in the Notch pathway promote NSC self-renewal.   
(A) Notch is a transmembrane receptor that is activated by binding its ligand Delta, 
which is expressed on the surface of neighboring cells. Upon activation, Notch is 
cleaved in its transmembrane domain, and the intracellular portion (NICD) translocates 
to the nucleus where it induces the expression of several genes, including the Hes 
family of transcriptional repressors. (B) Notch induces Hes1, which represses proneural 
genes like Ngn2 as well as itself.  Autoinhibition of Hes1 then allows for the induction of 
Ngn2, which induces the Notch receptor Delta.  The expression of Delta activates Notch 
signaling in neighboring cells.  Thus, waves of Notch signaling pass between adjoining 
cells, and the expression of pro-self-renewal factors is maintained.  (C) Hes1 and Ngn2 
expression oscillates in neural stem/progenitor cells (NPCs) with a periodicity of 2-3 
hours to maintain NSC identity.  NSCs differentiate when this complementary 
expression pattern is disrupted.   
Figure adapted from Kageyama et al., 2009. 
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transcriptional repressor that regulates proneural genes like Ngn2 as well as itself.  
Once Hes1 is activated, it binds to its own promoter, thereby reducing its own 
expression (Hirata et al., 2002).  In the absence of Hes1 repression, proneural genes 
are activated and induce the expression of Delta in that particular cell (Figure 5B).  
Thus, neighboring NSCs sustain Notch expression, and therefore NSC maintenance, by 
oscillating the expression of Notch effectors and proneural transcription factors.  When 
these periodic oscillations are broken, Ngn2 expression is sustained, and neuronal 
differentiation ensues (Shimojo et al., 2008). 
NSC transcription factor Pax6 plays a critical role in regulating the Hes1/Ngn2 
gene oscillations responsible for NSC self-renewal.  Genome-wide location analysis has 
revealed that Pax6 not only binds directly to NSC self-renewal genes like Hes1, but also 
to proneural genes like Ngn2 and Mash1/Ascl1 (Sansom et al., 2009).  Its effect on 
these genes is highly dose-dependent: whereas increased amounts of Pax6 lead to 
neurogenesis by inducing the proneural genes Ngn2 and Ascl1, decreased expression 
of Pax6 leads to neurogenesis by reducing the amount of Hes1 (Sansom et al., 2009).  
Thus, Pax6 preserves NSC self-renewal by regulating the Notch signaling/proneural 
transcription factor oscillatory network.   
 
 
This section has explored the nature of NSC formation in vivo and in vitro, as well 
as some factors that help to maintain the NSC phenotype.  The wealth of knowledge 
about this cell type, including its defined growth conditions, ability to proliferate 
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indefinitely in vitro, and stable transcriptional network, make NSCs an ideal cell type to 
test somatic cell conversions using defined factors.  Furthermore, although much is 
already known about NSCs, a detailed molecular understanding of their core 
transcriptional circuitry remains elusive.  Given the insight that the iPS reprogramming 
process has provided regarding the factors and pathways important for pluripotency, 
NSC regulatory mechanisms may be further elucidated by studying the induction of NSC 
characteristics in distant cell types.  Somatic cell conversion, or “transdifferentiation,” is 
a provocative idea, but its concepts are complex, as is its history. 
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Part III. Transdifferentiation and somatic cell conversion 
 
 
Definition of Transdifferentiation 
Transdifferentiation, also called direct conversion or lineage reprogramming, is 
defined as the conversion of one somatic cell state directly into a distinctly different 
somatic cell state without passing through pluripotency and re-differentiating (Wagers 
and Weissman, 2004; Graf and Enver, 2009; Hanna et al., 2010).  
This definition requires the following three criteria to be fulfilled to demonstrate 
transdifferentiation.  First, it requires a defined starting cell type.  Many primary cell 
cultures contain a heterogenous mix of cell types representing the tissue of origin.  For 
instance, although 80% of the adult liver is made up of hepatocytes, there are also a 
variety of non-epithelial cells present (Blouin et al., 1977), as well as the blood that 
innervates the organ.  When a tissue is explanted for growth in vitro, specific growth 
factors are often used to promote the survival and expansion of the desired cells. Since 
some conversion experiments occur at a low frequency, a contaminating cell could 
confound the results.  The true origin of a starting cell population can only be ensured 
by using genetic markings, like the DNA rearrangements found in blood cells or cell 
type-specific Cre-induced recombination, for retrospective analysis of the converted cell. 
Transdifferentiaton also requires the validation and functional characterization of 
a resulting cell type independent of exogenous perturbations.  The resulting cell must 
(1) express the unique markers of the endogenous target cell type; (2) fulfill the 
functional requirements of the endogenous cell type, such as differentiation or a cell 
 44!
type-specific process; and (3) reprogram its nucleus such that the gene expression and 
epigenetic state are similar to the endogenous cell type.  Additionally, all of these cell 
characterizations should be analyzed independent of the exogenous transgenes or 
chemicals that were used to impose the conversion to minimize any effect these 
perturbations may have had on the state.  Since naturally occurring cell states are 
stable, a cell that has been truly converted would be equally stable and would not need 
exogenous perturbations to maintain its properties.  Analysis in the absence of 
exogenous factors allows for the characterization and assessment of the intrinsic 
properties of the converted cell. 
A third requirement for transdifferentiation is that the process should not go 
through a pluripotent intermediate, which would be considered reprogramming with 
subsequent differentiation.  Reprogramming to pluripotency is a well-studied 
phenomenon, and differentiation is a natural property of pluripotent cells, so a 
conversion that goes through a pluripotent state would not need to acquire the 
properties of the target cell de novo and therefore would not be a “direct” conversion.  
Since pluripotency can happen transiently, a genetic mark is one way this could be 
shown.  For instance, the pluripotent state could be assessed by a Cre allele driven by a 
key pluripotency gene (such as Pou5f1), which would genetically mark any cells that 
induce expression of that gene.  Another option would be to genetically knock out a key 
pluripotency gene in the somatic donor cell so that pluripotency cannot be attained.   
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Although transdifferentiation has a somewhat narrow definition, it falls under a 
larger category of “cell conversion,” which is a more general term used to describe the 
process of changing a cell!s typical fate. 
 
Review of transdifferentiation/direct conversion experiments 
 Numerous experiments have been performed to test the concept of 
transdifferentiation.  The following is a critical review of these works with an emphasis 
on the three criteria for transdifferentiation discussed above. 
 
The discovery of MyoD 
The discovery that transcription factors can be used to convert somatic cells to 
pluripotency was a tremendously important finding and has revolutionized the fields of 
regenerative medicine and stem cell biology.  However, the principles of defined factor-
mediated conversion are rooted in a series of seminal experiments that occurred 
decades earlier.  In the 1980!s, Harold Weintraub and colleagues were interested in 
identifying factors that regulate cell type-specific gene expression and then determining 
what effect these factors may have when expressed in an unrelated cell type (Tapscott, 
2005).  The experimental system they used was the 10T1/2 fibroblast cell line, which 
had been shown to produce subclones with myogenic, adipogenic, or chondrogenic 
phenotypes upon exposure to the demethylating agent 5-azacytidine (Constantinides et 
al., 1977; Taylor and Jones, 1979).  Reasoning that this conversion may be due to the 
random expression of undermethylated genes, the scientists made DNA libraries from 
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the aza-converted myoblast-like cell lines, as well as from the parental fibroblast line 
and an immortalized myoblast cell line (Lassar et al., 1986).  Upon DNA transfection into 
fibroblasts, they found that DNA from either the aza-converted cells or the immortalized 
myoblasts can induce myogenic colonies, whereas DNA from fibroblasts had no effect 
(Lassar et al., 1986).  Myod was found to be the single gene responsible for this 
myoblast determination, and its overexpression had a similar effect on multiple fibroblast 
cell lines (Davis et al., 1987). 
This elegant series of experiments had a profound impact on our understanding 
of differentiation and gene regulation.  First, the discovery that Myod transduction was 
sufficient to initiate a myogenic differentiation pathway indicated that cell type-specific 
factors may have crucial roles in cell specification (Davis et al., 1987).  Indeed, the 
identification of Myod allowed for other tissue-specific transcription factors to be 
identified by virtue of their homology with Myod (Massari and Murre, 2000).  Also, 
subsequent studies on the family of myogenic transcription factors elucidated general 
principles of mammalian gene regulation, the collaborative and antagonistic relationship 
between certain transcription factors, and the molecular initiation of the differentiation 
process (Tapscott, 2005).  Importantly, the discovery of Myod demonstrated that the 
overexpression of key transcription factors in certain cell types can override the cell!s 
endogenous gene expression pattern and change its normal fate. Although the effect of 
Myod was induced through its constitutive expression in fibroblasts, and it was not 
sufficient to fully convert distantly related cell types like neuroblastoma and melanoma 
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cells (Weintraub et al., 1989), these seminal experiments laid the groundwork for 
defined factor-mediated reprogramming and somatic cell conversion. 
 
The “plasticity” of bone marrow stem cells 
After the discovery of Myod, interest grew in exploring the plasticity of adult 
mammalian cells and testing the limits of somatic cell conversion and 
transdifferentiation.  A number of studies reported an incredible plasticity in bone 
marrow (i.e. mesenchymal) stem cells—when transplanted, these cells could convert 
into diverse cell types like skeletal muscle (Ferrari et al., 1998), cardiomyocytes and 
cardiac endothelium (Jackson et al., 2001), pancreatic "-cells (Ianus et al., 2003), 
neurons (Brazelton et al., 2000; Mezey et al. 2000), and epithelial cells of the skin, liver, 
lung, and intestine (Krause et al. 2001).  Many of these studies relied on activation of 
donor-specific reporters in the host tissue as evidence for conversion.  However, upon 
closer examination, it was determined that the observed “plasticity” of the bone marrow 
stem cells was not cell conversion, but the result of a fusion event between the stem 
cell!s natural progeny and host cells (Wagers et al. 2002; Camargo et al., 2003). 
In addition to mesenchymal stem cell!s (MSC!s) purported ability to differentiate 
into neural cells upon transplantation, they were also reported to have amazing plasticity 
in vitro.  MSCs exposed to chemical agents like DMSO or "–mercaptoethanol 
supposedly could be spontaneously converted to neurons and glia (Sanchez-Ramos et 
al., 2000, Woodbury et al., 2000).  The cells! morphology was consistent with 
differentiated neural cells, and they stained for the neural differentiation markers 
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neuron-specific nuclear protein (NeuN), "-III tubulin (Tuj1), and glial fibrillary acidic 
protein (GFAP).  Additionally, these cells were reported to have functional properties like 
calcium uptake and electrophysiological activity typical of functional mature neurons 
(Kohyama et al., 2001).  However, these experiments were later shown to be an artifact 
of the experimental system.  The cells had not been converted to neuronal cells, but 
instead had undergone extreme morphological changes.  Time-lapse imaging showed 
that the processes and neurites observed after this neural “induction” were actually the 
result of cytoplasmic retraction in response to the cytotoxic agents and not from process 
extension, which happens during neuronal differentiation (Lu et al., 2004; Neuhuber et 
al., 2004).  Furthermore, the protein and gene expression changes were likely due to 
aberrant gene expression changes in response to stress or to background expression 
coupled with an extreme change in morphology (Neuhuber et al., 2004).   
The studies reporting the in vivo and in vitro plasticity of bone marrow stem cells 
highlight the complexities involved with cell conversion experiments.  The use of an ill-
defined starting population of bone marrow stem cells isolated using slightly different 
protocols by each group makes it difficult to know which starting cell was responsible for 
this effect (Theise et al., 2003).  Furthermore, many of the reports relied on in vitro 
morphology or in vivo location and not on a functional assessment of the “converted” 
cell; therefore, their results were over-interpreted.  Finally, conversion was often 
quantified by the reactivation of a cell type-specific reporter present but not expressed in 
the donor cell. However, donor-specific gene expression was not assessed for 
repression and may have remained active following cell fusion. 
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The artifactual results of the mesenchymal stem cell experiments cast doubt on 
the feasibility of in vitro transdifferentiation and somatic cell conversion (Graf, 2011).  
However, interest in the topic was reignited by Takahashi and Yamanaka!s discovery 
that the overexpression of key transcription factors can convert somatic cells into 
pluripotent stem cells (Takahashi and Yamanaka, 2006).   
 
Hematopoietic Conversions 
A number of studies have tried Yamanaka!s approach of overexpressing 
transcription factors to find the factor or factor combination that can induce specific cell 
types.  Transcription factors were shown to re-specify cells within the hematopoietic 
lineage.  Forced expression of the erythroid-megakaryocyte transcription factor GATA-1 
in monocytes induced these cells to undergo an erythroid-, eosinophil-, or basophil-like 
cell fate (Heyworth et al., 2004).  Also within the hematopoietic lineage, Graf and 
colleagues found that overexpression of C/EBP# and PU.1 in B- and T-lymphocytes 
gives them macrophage properties like cell-surface marker expression, morphology, 
and phagocytic capacity consistent with macrophages (Xie et al., 2004, Laiosa et al., 
2006).   However, the extent of conversion is unclear since the converted cells rely on 
constitutive expression of the exogenous factors, and they also maintain expression of a 
number of donor-specific markers (Hanna et al., 2010).  Furthermore, overexpression of 
C/EBP# and PU.1 in more distantly related fibroblasts resulted in pseudo-converted 
cells whose phenotype would revert to fibroblast-like unless they were stabilized through 
continuous expression of the exogenous transcription factors (Feng et al., 2008). 
 50!
Other Non-Neural Conversions 
Recently, many reports have claimed the induction of particular cell types by 
overexpressing key transcription factors. However, these studies do not fulfill the criteria 
for direct conversion because they do not demonstrate that the cell created can function 
without exogenous factor expression.  For instance, studies showing the generation of 
brown fat cells by overexpressing C/EBP" and PRDM16 in fibroblasts (Kajimura et al., 
2009), as well as the creation of hepatocyte-like cells with factors Gata4, Hnf1#, and 
FoxA3 (Huang et al., 2011; Sekiya and Suzuki, 2010), used constitutive retroviruses or 
constitutive lentiviruses for factor transduction, making it impossible to determine the 
extent of conversion.  Buganim et al. (2012) used doxycycline (dox)-inducible 
lentiviruses to show that embryonic sertoli-like cells can be induced from fibroblasts 
through the overexpression of factors Gata4, Nr5a2, Wt1, Dmrt1, and Sox9, but their 
analysis was performed only in the presence of dox, and therefore exogenous factor 
expression.  An elegant study demonstrated that cardiac fibroblasts and tail-tip 
fibroblasts could be converted into cardiomyocytes through the overexpression of 
Gata4, Mef2c, and Tbx5 (Ieda  et al., 2010).  Although the authors showed their induced 
cells express genes present in cardiomyocytes after exogenous factor withdrawal, they 
rely on constitutive retroviral expression for the functional cardiomyocyte assays of in 
vivo engraftment, spontaneous contraction, and electrophysiology. 
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Post-mitotic neural cell conversions 
Many direct conversion studies have focused on creating cells of the neural 
lineage, and both post-mitotic cells and proliferating cells have been generated in vitro.  
Overexpressing three factors in mouse fibroblasts—Brn2, Ascl1, and Mytl1 (BAM)—can 
create post-mitotic induced neuron-like (iN) cells (Vierbuchen et al., 2010), and human 
fibroblasts can be converted by supplementing BAM with NeuroD1 (Pang et al., 2011).  
Within one cell division and 2-3 weeks of factor induction, mouse fibroblasts express 
multiple neuron-specific proteins, generate action potentials, and form functional 
synapses; however, nearly all of the analysis was performed in the presence of the 
exogenous factors.  Although Wernig and colleagues later show that the neuron-specific 
marker TuJ1 persists in the iN cells made from hepatocytes after the de-induction of 
BAM, they did not assess the functional activities of these cells by measuring action 
potentials or show functional synaptic properties in cells that do not express the 
transduced factors (Marro et al., 2011). 
In addition to generic neurons, cells with characteristics of subtype-specific 
neurons have also been generated.  Induced motor neurons (iMNs) can be created with 
forced expression of a pool of 7 transcription factors in mouse or human fibroblasts (Son 
et al., 2011).  iMNs have motor neuron gene expression, electrophysiology, and the 
ability to induce muscle cell contractions in vitro, and they can integrate into developing 
chick spinal cords (Son et al., 2011).  However, the true identity of these cells is 
ambiguous because there is no epigenetic analysis to show conversion, and the 
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exogenous factors are expressed at levels 300-1600 fold higher than background in iMN 
cells (Son et al., 2011). 
Cells with qualities of dopaminergic (DA) neurons have also been induced with 
the overexpression of key transcription factors (Caiazzo et al., 2011; Pfisterer et al, 
2011; Kim et al., 2011).  The induced dopaminergic (iDA) neurons have properties of 
endogenous DA neurons, including characteristic morphology, production of tyrosine 
hydroxylase and other markers of DA neurons, and electrophysiology.  The authors use 
dox-inducible transgene expression to show that most of these qualities persist after 
exogenous factor withdrawal; however, it is unclear if iDA neurons are molecularly and 
functionally equivalent to primary DA neurons because the gene expression and the 
majority of functional assays were only assessed in the presence of dox (Caiazzo et al., 
2011; Kim et al., 2011).   
Direct conversion into a differentiated, post-mitotic cell type inherently makes it 
difficult to analyze the molecular features of the cells.  Since the cells do not divide, it is 
impossible to generate a large, clonal population of cells needed for accurate gene 
expression, epigenetic, or biochemical analyses.  Instead, many of the assays are either 
performed on single cells, which may or may not represent the larger population, or on a 
heterogeneous mix of cells that have different integrations and expression levels from 
the exogenous factors, which can be misleading especially since many studies analyze 
the cell in the presence of the factors.  Moreover, modulating the epigenetic status of 
cells during iPS reprogramming requires multiple cell divisions (Hanna et al., 2009), and 
with limited epigenetic analyses performed on “converted” cell types—and none in the 
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absence of exogenous factors—it is impossible to know if these post-mitotic cells were 
able to modulate their epigenomes to be like the endogenous cells without dividing.  
Furthermore, it is not immediately obvious what would happen to an incompletely 
reprogrammed post-mitotic cell in the absence of the exogenous factors, since it would 
not have subsequent cell divisions to establish or revert its epigenome.  Although it has 
been demonstrated that the post-mitotic cells have the morphology and express 
structural proteins consistent with their target cell types, it should be noted that 
transcription factor expression, genome-wide gene expression or epigenetic analysis, 
and assays showing cell functionality have not been reported. 
 
Proliferating neural cell conversions 
The problems associated with direct conversion into a post-mitotic cell type may 
be mitigated with the generation of a dividing cell, which has also been achieved within 
the neural lineage with the creation of induced neural stem cells and also induced 
oligodendrocyte precursor cells.  Han et al. (2012) demonstrate that induced neural 
stem cells (iNSCs) can be generated through the forced expression of Sox2, Klf4, Myc, 
Brn4, and Tcf3.  These cells display the morphological, gene expression, and functional 
properties of NSCs, but they are created with constitutive retroviruses, which leads to 
varying levels of exogenous factor expression in the final cells (Han et al., 2012).  Also, 
the generation of iNSCs is a slow and inefficient process resulting in just a couple of 
iNSC lines, making it unclear how reproducible this technique is.  In addition, Southern 
blot analysis was not employed to ensure that the cell lines arose independently.  The 
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inefficiency of their conversion may be due to the presence of rare neural progenitors 
residing in the MEF starting population.  Although brain cells and internal organs were 
removed for the creation of MEFs, the neural tissue of the spinal cord was not removed, 
and the transformation of neural progenitors originating there cannot be excluded. 
Wernig and colleagues were able to generate neural stem-like cells from 
embryonic fibroblasts that had been manually dissected away from the spinal and brain 
neural cells (Lujan et al., 2012).  They found that overexpression of three transcription 
factors—Sox2, Brn2, and FoxG1—leads to the creation of cells that resemble NSCs by 
marker expression and differentiation capacity (Lujan et al., 2012).  However, it should 
be noted that these cells differentiate spontaneously upon exogenous factor withdrawal 
and therefore have not activated the endogenous NSC transcriptional circuitry 
necessary for maintaining themselves. 
Another proliferating cell type that has been generated in vitro through 
transcription factor overexpression in fibroblasts is induced oligodendrocyte precursor 
cells (iOPCs).  Through the forced expression of Sox10 and Olig2, and combinations of 
additional factors for three weeks, two groups were able to create transient precursor 
cells that are restricted to forming either both astrocytes and oligodendrocytes (Yang et 
al., 2013) or just oligodendrocytes (Najm et al., 2013).  The generation of 
oligodendrocyte-like cells may have therapeutic implications, as evidenced by their 
efficacy in rescuing the hypomyelineation phenotype of the shiverer mutant mouse upon 
transplantation (Yang et al., 2013; Najm et al., 2013; Chernoff, 1981).  However, it 
remains to be determined how potent these factors are in generating bona fide iOPCs, 
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since the exogenous factors are expressed throughout the generation, differentiation, 
and terminal maturation of the iOPCs.  Moreover, Wernig and colleagues maintained 
induction of the transduced factors after transplantation into the shiverer mouse by 
adding the inducing agent to the drinking water (Yang et al., 2013), so it is unclear if the 
correction of the myelination defect would occur without continuous transgene 
expression. 
Direct conversion into a proliferating cell type is more compelling than into a post-
mitotic cell.  Having numerous cell divisions would allow the induced cell to modify and 
reset its epigenome to ensure that the gene expression and other changes that have 
occurred can be maintained over time.  Furthermore, multiple cell divisions after 
transgene withdrawal may result in a more accurate representation of the true nature of 
the induced cell because the results of functional and other assays would not be 
obscured by a large amount of exogenous factor expression. 
  However, the proliferative nature of the induced cell also presents some added 
complications for analyzing direct conversion experiments.  For one, since the cells are 
cultured long-term after factor induction, a rare somatic cell—like a somatic stem cell or 
endogenous version of the target cell—that contaminates the starting cell population 
could conceivably have enough divisions to grow out and be observed as a “converted” 
cell, thus making it difficult to determine the true extent of conversion.  A second issue 
arising from the numerous cell divisions required to induce and maintain the target cell 
is that the cell may transiently go through a pluripotent intermediate step.  Although the 
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correct target cell would be generated, it would not be through “direct conversion,” but 
rather through reprogramming to pluripotency and subsequent differentiation. 
 
How similar are converted cells and their endogenous counterparts? 
 Cells created through direct conversion share many features with their in vivo, 
natural counterparts; however, it remains to be seen if the two are functionally and 
molecularly equivalent.  Virtually all the studies claiming “direct conversion” characterize 
the induced cells in the presence of exogenous factors.  This makes it difficult to 
determine if the observed phenotypes are intrinsic to the induced cell or are artifacts of 
transgene overexpression.  For instance, gene expression analysis in the presence of 
exogenous factors makes it unclear if the endogenous core transcriptional circuitry 
governing cell type-specific gene expression has been fully activated.  Furthermore, the 
overexpression of transduced factors complicates the interpretation of functional assays 
because it is not clear how much of the cells! perceived functionality is contributed by 
the exogenous factors.  Without comprehensive epigenetic analysis, it is unknown if the 
unique, cell type-specific epigenetic marks that maintain proper gene expression have 
been established and are maintained independently of exogenous transgene 
overexpression.   
 
Therapeutic implications of direct conversion 
The direct conversion technology may have a tremendous effect on cell-based 
therapies because it can potentially be used to create cell types that are otherwise 
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difficult to generate.  There are currently two strategies for applying direct conversion— 
converting cells in vivo, or converting cells in vitro and then transplanting them in vivo. 
There have been a few reports that indicate that cells can be generated in vivo 
for cell therapy.  One example is the conversion of pancreatic exocrine cells into "-cells 
through the forced expression of Ngn3, Pdx1, and MafA (Zhou et al., 2008), which may 
be of interest for the treatment of diabetes.  Another clinically relevant example of in vivo 
conversion is the generation of cardiomyocytes from cardiac fibroblasts by 
overexpressing Gata4, Mef2c, and Tbx5 in the heart (Qian et al., 2012).  However, 
factor delivery remains a technical impediment for this technique, since vector 
integration into the patient genome can have detrimental effects for the patient (Hacein-
Bey-Abina et al., 2003).  Also, some conversions, such as the induction of "-cells from 
exocrine cells, only occur with certain starting cell types (Zhou et al., 2008), so it is 
unclear how the factors will be introduced specifically to the relevant cells.  When these 
technical issues have been solved, this may be a valuable tool for treating patients with 
certain disorders with their own cells. 
Transplantation can provide a better therapeutic option for genetic disorders 
because causative mutations can be corrected in vitro, and healthy cells can be 
introduced to the patient.  This strategy has been shown to be effective in treating 
dysmyelination and Parkinsonian symptoms in mice (Yang et al., 2013, Najm et al., 
2013, Kim et al., 2012).  However, since the cells created thus far have not been shown 
to function independently of exogenous factor expression, it remains to be determined if 
they can be generated without introducing transgenes into the genome.  
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Reprogramming cells to iPS and then re-differentiating them may be a more suitable 
option for therapy, since iPS cells can be generated without modifying the genome, they 
can be checked for their karyotype or for other mutations, and disease-relevant 
mutations can be corrected in iPS cells (Hanna et al., 2007).  
 
Biological implications of direct conversion 
The discovery that cells can be reprogrammed to pluripotency had an enormous 
impact on the understanding of epigenetic plasticity in differentiated cells, and 
elucidating the interconversion of differentiated cell types would further refine our 
understanding.  Although pluripotent cells are readily induced and stabilized in vitro, it is 
not known if other cell types can be stably induced and maintained in a similar manner.  
A convincing demonstration of direct conversion would show that the pluripotent state is 
not uniquely attainable and that the epigenome of other cell types can also be stabilized 
in vitro from somatic sources. Furthermore, factors capable of inducing direct 
conversion may hint at the key regulators of that somatic cell type, just as Oct4, Sox2, 
Klf4, and Nanog are crucial for pluripotent cells.  Additionally, true direct conversion 
would provide another system to analyze the transcription factors, chromatin modifiers, 
and other genes involved with repressing a differentiated cell!s chromatin and 
establishing an unrelated cell type.  
It is unclear how much novel information is gained from the current direct 
conversion experiments.  Weintraub and colleagues! discovery that the forced 
expression of Myod can give myoblast characteristics to a distantly related cell type was 
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a novel discovery because at the time it was not known how cells undergo cell type-
specific gene expression changes or what factors may be responsible for initiating a 
differentiation process.  Now, however, we know all of the genes in the genome, as well 
as their expression patterns in many cell types.  Current direct conversion experiments 
are generally performed by choosing factors thought to be important for the target cell 
type (based on genetic, gene expression, biochemical, etc. analyses), overexpressing 
these factors in an unrelated cell type, and then monitoring the cells in the presence of 
the exogenous factors for phenotypes that the factors were thought to be critical for.  If, 
however, the transduced cells were analyzed in the absence of the exogenous factors, 
the results may reveal which factors are the most important critical regulators for 
establishing and/or maintaining cell identity.  As outlined in Table 1 and Table 2, few (if 
any) of the currently published studies have completely characterized the functional 
properties of converted cells in the absence of exogenous factors, so it is unclear what 
the biological implications of these studies are. 
The work presented in this thesis attempts to address some of the shortcomings 
of the previous direct conversion experiments.  Self-maintaining neural stem cells have 
been generated from mouse embryonic fibroblast cultures by overexpressing factors 
shown to be important for this cell type.  These cells have been characterized in the 
absence of exogenous factor induction and were shown to differentiate and be 
transcriptionally and epigenetically similar to endogenous embryonic cortical neural 
stem cells.  Finally, a “secondary” system has been created for reproducibly generating 
neural stem cells without additional factor transduction.
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SUMMARY 
 
The overexpression of four transcription factors Oct4, Sox2, Klf4, and c-Myc reprograms 
a somatic nucleus to one that is transcriptionally and epigenetically indistinguishable 
from an embryonic stem (ES) cell.  However, it is still unclear if transcription factors can 
completely convert the nucleus of a differentiated cell into that of a distantly related cell 
type with complete transcriptional and epigenetic reprogramming maintained in the 
absence of exogenous factor expression.  To test this idea, we generated doxycycline 
(dox)-inducible vectors encoding neural stem cell-expressed factors.  We found that 
stable, self-maintaining NSC-like cells could be induced under defined growth conditions 
after transduction of factors including Brn2, Hes1, Hes3, Klf4, Myc, Notch, PLAGL1, 
Rfx4, and dominant-negative REST.  These cells were characterized in the absence of 
exogenous factor induction and were shown to be transcriptionally, epigenetically, and 
functionally similar to endogenous embryonic cortical NSCs.  Additionally, a cellular 
system was created for reproducible generation of dox-independent iNSCs without 
additional factor transduction.  Our results show that a transcriptionally and 
epigenetically reprogrammed somatic nucleus can be stabilized in vitro providing a tool 
to study the mechanism of somatic cell conversion. 
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INTRODUCTION 
 
Factor-mediated reprogramming, the process by which overexpression of a 
defined set of transcription factors converts one cell type into another, has important 
implications for regenerative medicine and demonstrates the power that transcription 
factors have as cell fate determinants (Jaenisch and Young, 2008).  This has been 
shown for pluripotent stem cells, where three transcription factors (Oct4, Sox2, and Klf4) 
are sufficient to induce any cell type to become an induced pluripotent stem (iPS) cell 
(Takahashi and Yamanaka, 2006; Okita et al., 2007; Wernig et al., 2007; Nakagawa et 
al., 2008; Wernig et al., 2008a).  iPS cells are transcriptionally, epigenetically, and 
functionally indistinguishable from embryonic stem (ES) cells (Okita et al., 2007; Wernig 
et al., 2007; Boland et al., 2009; Zhao et al., 2009).  The overwhelming biological and 
medical interest in iPS cells driven attempts to generate other cell types through forced 
expression of defined factors. 
However, pluripotency may represent a unique cellular state that is more 
attainable in vitro than a somatic one (Hanna et al., 2010).  This has been suggested by 
cell fusion experiments, which show that ES cells express dominant trans-acting factors 
that can induce a somatic nucleus to become pluripotent upon cellular fusion (Tada et 
al., 2001).  Also, pluripotent cells express a set of well-characterized transcription 
factors that are known to regulate each other, thereby forming an endogenous 
autoregulatory gene circuitry (Boyer et al., 2005) that may maintain the ES cell state 
once it is activated.  Pluripotency may be further stabilized in vitro by its unique 
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epigenetic environment, which includes the regulators responsible for silencing 
retroviruses specifically in pluripotent cells (Wolf and Goff, 2007; Jahner et al., 1982) as 
well as a destabilized nucleosome remodeling and histone deacetylation (NuRD) 
complex (J. Hanna, unpublished data).  Furthermore, the growth advantage that 
pluripotent cells have over somatic cells and their dome-like morphology may aid the 
detection of rare reprogramming events. 
Recently, a number of cell types have been generated by the forced expression 
of key transcription factors, including cells resembling blood cells (Heyworth et al., 2004; 
Xie et al., 2006), brown fat cells (Kajimura et al., 2009), hepatocytes (Sekiya and 
Suzuki, 2010; Huang et al., 2011), sertoli cells (Buganim et al., 2012a), and various cells 
of the neural lineage (Veirbuchen et al., 2010; Kim et al., 2011; Son et al., 2011; Han et 
al., 2012; Lujan et al., 2012; Najm et al., 2013; Yang et al., 2013).  However, it is unclear 
how similar these cells are to their endogenous counterparts because they were 
generated either with constitutive or with inducible vectors, but were functionally and 
molecularly characterized in the presence of the inducing agent.  Furthermore, an 
extensive epigenetic analysis has not been performed to determine if the chromatin has 
been reset to allow for cell type-specific gene expression to persist in the absence of the 
exogenous factors.  Cell type conversion requires analysis of the resulting cells in the 
absence of exogenous factors to assess the intrinsic qualities of the cell (Wager and 
Weissman, 2004; Graf and Enver, 2009; Hanna et al., 2010). 
The induction of stable iPS cells requires multiple cell divisions (Hanna et al., 
2009).  Reasoning that defined-factor-mediated induction of a somatic cell type may 
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also require multiple cell divisions to establish a stable epigenetic state, we sought to 
generate neural stem cells (NSCs)—the multipotent precursors of the developing 
mammalian nervous system.  NSCs are readily grown in vitro and can be generated 
either by explanting them directly from the developing or adult mouse brain (Doetsch et 
al., 1999) or by deriving them in vitro by differentiating ES cells in a defined medium 
containing insulin, transferrin, selenium, and fibronectin (ITSFn) (Okabe et al., 1996). 
The in vitro derived cells share the features of their in vivo counterparts, including the 
ability to self-renew indefinitely in the presence of EGF and FGF, as well as the ability to 
differentiate into both neurons and glia upon growth factor withdrawal (Okabe et al., 
1996). 
 Several factors are known to have important roles in NSC biology and/or are 
preferentially expressed in NSCs.  For instance, Notch and its effectors are critical for 
NSC maintenance (Imayoshi et al., 2010), as are Sox9 (Scott et al., 2010) and the 
redundant SoxB1 transcription factors Sox1, Sox2, and Sox3 (Bylund et al., 2003; 
Graham et al., 2003). POU-domain proteins like Brn1 and Brn2 are known to bind 
collaboratively with Sox proteins and enhance their induction of target genes (Dailey 
and Basilico, 2001), and the Rfx and NF-I binding motifs were found at Sox2/Brn2 co-
bound sites (Lodato et al., 2013), which suggests that these factors may also have 
prominent NSC regulatory roles as well. Many genes like Plagl1, Plzf, Lhx2, and Zic1 
are highly expressed in rosette-stage NSCs, an early NSC type with broad 
differentiation potential (Elkabetz et al., 2008; Elkabetz and Studer, 2008). 
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In the present study, we generated self-maintaining neural stem cells from mouse 
embryonic fibroblast cultures by transducing the cells with a pool of defined factors 
known to be important for neural stem cells and then growing the cells in defined growth 
conditions.  These induced NSCs (iNSCs) can differentiate in vitro and in vivo and have 
similar genome-wide gene expression patterns and enhancer usage as primary NSCs 
isolated from developing mouse brains. Finally, we demonstrate the reproducibility of 
this process by establishing a "secondary! system in which iNSCs can be generated 
from embryo chimeras containing cells with clonal iNSC proviral integrations that can be 
induced without the need for additional factor transduction.  These findings demonstrate 
that a non-pluripotent somatic cell can be reproducibly induced that maintains itself in 
the absence of exogenous factor overexpression with a transcriptionally and 
epigenetically reprogrammed nucleus. 
 
RESULTS 
!
Defined growth conditions promote the induction of self-maintaining NSCs by defined 
factors 
A library of neural stem cell (NSC)-expressed transcription factors and chromatin-
modifying factors thought to be important for NSCs or with NSC-enriched gene 
expression was created for overexpression in fibroblasts (Table S1) (Bylund et al., 2003; 
Elkabetz et al., 2008; Imayoshi et al., 2010; Scott et al., 2010).  In addition to NSC 
factors, a dominant-negative version of the RE1-silencing transcription factor (DN-
REST) was included to inhibit the endogenous Rest complex, which silences neural 
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genes in non-neural cell types (Ballas and Mandel, 2005; Chong et al., 1995).  The 
library also included the neuronal induction factors Ascl1, Myt1l, and mir124a 
(Ambasudhan et al., 2011; Yoo et al., 2011; Vierbuchen et al., 2010) as well c-Myc, 
which acts as an amplifier of gene expression and may serve a general role during 
reprogramming (Lin et al., 2012; Nie et al., 2012; Bugamin et al., 2013).  All transgenes 
were controlled by the doxycycline (dox)-inducible Tet-On promoter to regulate 
exogenous factor expression. 
! Fibroblasts from the Sox2-GFP reporter mouse, in which one allele of the 
endogenous Sox2 gene was replaced by GFP, were used to monitor for NSC properties 
in transduced cells (Ellis et al., 2004).  In the mouse embryo, Sox2 is highly expressed 
in the developing neural tissues (Ellis et al., 2004; Avilion et al., 2003; Zappone et al., 
2000), but also found in other somatic stem cell compartments (Arnold et al., 2011).  
The Sox2 expressing neural tissue was removed by dissection, and the rare GFP+ cells 
that remain have been shown to not have neural characteristics (Lujan et al., 2012). 
 Initially, the strategy to generate NSC-like cells was to transduce the pool of 
factors into MEFs and then culture the cells in NSC medium that contained dox (Figure 
S1A).  GFP analysis showed a weakly-positive population of Sox2-GFP+ cells that 
increased over time after factor induction (Figure S1B).  These cells could be grown in 
vitro as adherent cultures or as neurosphere-like floating cultures (Figures S1C and 
S1D), and FACS-sorted cells stained for the NSC marker Nestin (Figure S1E).   
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Figure S1. Generation of transgene-dependent NSC-like cells with limited NSC 
characteristics 
 
(A) Experimental strategy for inducing NSCs from fibroblasts.  After library transduction, 
cells were grown with dox for 3-4 weeks (4 days in MEF medium and then in neural 
induction medium), then GFP was analyzed, and cells were replated without dox.   
(B) Left, time course of Sox2-GFP expression in transduced and untransduced MEFs.  
Right, representative FACS plots.  The APC channel was used to control for 
autofluorescence.  (C) Sox2-GFP+ cells could grow as spheres and proliferate over 
time.  Note that the sphere marked with an arrowhead expanded over a 2 day time 
frame.  Images were taken using the same microscope objective.  (D) Morphology and 
Sox2-GFP fluorescence of transduced cells growing as adherent spheres and 
monolayer culture.  (E) Immunostaining for Nestin in adherent cells sorted for Sox2-
GFP+ expression.
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However, these Sox2-GFP+ cells remained dependent on the exogenous transgenes 
for survival, as they did not survive dox withdrawal (data not shown). 
 To screen for conditions that could produce NSC-like cells able to be maintained 
independent of dox, we varied both the exogenous factors and the culture conditions.  
First, MEFs from E12.5 embryos were used, since these cells were from an earlier 
embryonic period than the typical (E14.5) MEFs and therefore may be more amenable 
to generating self-maintaining NSCs in vitro by defined factors.  Additionally, dox was 
withdrawn, and NSC-like cells were selected for during a period of growth in ITSFn, a 
medium that is normally used during ES cell differentiation to NSCs to select for Nestin-
expressing cells (Okabe et al., 1996).  Finally, specific factors or groups of factors were 
omitted from the viral pools used to transduce MEFs to assess whether certain factors 
were detrimental for dox-independent NSC formation (Figure 1A). 
GFP expression was measured at two time points: before ITSFn selection while 
the cells were on dox, and again three weeks after dox withdrawal (Figure 1A).  We 
found robust activation of the Sox2-GFP reporter with most factor combinations in the 
presence of dox. No Sox2-GFP induction was seen in the uninfected control cultures 
and when both Notch (NICD) and its effector Hes1 were omitted (Figure 1B), supporting 
the finding that Notch signaling is important for the maintenance of NSCs (Kageyama et 
al., 2009; Imayoshi et al., 2010).  Many of the factor combinations that induced robust 
Sox2-GFP expression in the presence of dox had reduced or no GFP expression 
following dox withdrawal.  In fact, only one factor combination—the pool in which Olig1,  
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Figure 1. Defined growth conditions promote the induction of NSC-like cells from 
fibroblasts 
 
  
(A) Experimental strategy for inducing and selecting transgene-independent NSC-like 
cells from transduced E12.5 MEFs.  Dox was withdrawn on day 4 of a 10 day growth 
period in a neural selection medium (ITSFn).  See methods section for experimental 
details.  (B) Sox2-GFP fluorescence measured at two time points—before (blue bars, 
GFP Analysis 1) and after (red bars, GFP Analysis 2) dox withdrawal.  The * denotes 
transduction that generated dox-independent NSC-like cells, also called iNSCs.  (C) 
FACS plots showing the Sox2-GFP expression of dox-independent cells (iNSCs).  A 
Sox2-GFP-negative culture from the same experiment is shown for reference.  The APC 
channel was used to control for autofluorescence.  (D) Morphology and Sox2-GFP 
fluorescence of iNSCs sorted for Sox2-GFP+ cells (Sorted iNSCs), as well as primary 
cortical NSCs from Sox2-GFP mouse (Primary NSCs), and MEFs.  (E) Immunostaining 
of sorted iNSCs for NSC markers Nestin, Sox2, and Sox1.  (F) Quantitative PCR 
comparing the expression of fibroblast genes Col5a2 and Thy1 and NSC genes Sox1, 
Nestin, and Brn1 in ES cells, MEFs, E14.5 derived neurospheres (E14.5 NS), and the 
iNSCs.  Values were normalized to Gapdh expression for each cell type. 
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Olig2, and Ngn2 were omitted—showed an increase in the Sox2-GFP+ fraction 3 weeks 
after dox withdrawal (Figure 1B).  The GFP expression of these cells was distinct from 
the Sox2-GFP-negative population (Figure 1C), and it was much stronger than the weak 
GFP expression of the dox-dependent Sox2-GFP+ cells (comparing Figure S1A and 
Figure 1C).  In pools containing Olig1, Olig2, and Ngn2, the cultures were overgrown by 
GFP-negative cells after dox withdrawal, which may have masked the generation of 
Sox2-GFP+ cells (data not shown).  
The dox-independent Sox2-GFP+ cells were isolated by FACS and could be 
expanded in the presence of EGF and FGF with a morphology and GFP expression 
similar to primary cortical NSCs isolated from Sox2-GFP+ embryos (Figure 1D). The 
sorted cells had the same growth factor dependence as primary NSCs in that they 
proliferated rapidly in the presence of EGF/FGF or EGF alone, but experienced slower 
proliferation or cell death upon EGF withdrawal from EGF/FGF cultures (Figure S2 and 
S3) (Conti et al., 2005; Pollard et al., 2006).  The sorted cells stained for the NSC-
expressed intermediate filament Nestin, as well as the endogenous transcription factors 
Sox1 and Sox2 (Figure 1E).  Importantly, quantitative PCR (qPCR) analysis showed that 
these cells expressed the neural genes Nestin, Sox1, and Brn1, but did not express the 
fibroblast genes Col5a2 or Thy1 (Figure 1F).  
Shortly after growth factor withdrawal, the Sox2-GFP+ sorted cells began to 
express doublecortin (Dcx) (Figure 2A), which is normally expressed in differentiating 
NSCs (Francis et al., 1999).  The cells differentiated into neuronal and glial cells, 
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Figure S2. iNSC growth factor dependence  
 
Morphological analysis of iNSCs 24 and 48 hours after being plated with the indicated 
growth factors.  iNSCs display a similar growth dependence as that reported for ES cell-
derived NSCs (Conti et al., 2005; Pollard et al., 2006). EGF20 is 20 ng/ml EGF and 
FGF20 is 20 ng/ml FGF. 
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Figure S3. iNSC morphological changes upon differentiation 
 
Morphological analysis of iNSCs cultured for 4 days in either growth medium (containing 
EGF and FGF) or a differentiation medium (containing forskolin, FGF, and PDGF) 
(Glaser et al. 2007). 
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which immunostained for "-III tubulin (TuJ1) and glial fibrillary acidic protein (GFAP), 
respectively (Figure 2B).  When allowed to spontaneously differentiate in the absence of 
growth factors, differentiation was skewed toward astrocytes (Figure S4), as has been 
reported for NSCs grown in vitro (Mikkelsen et al., 2008; Conti et al., 2005).  
The ability of these induced cells to integrate, migrate, and differentiate in vivo 
was assessed by labeling them with a constitutive tdTomato lentivirus (FUW-tdTomato) 
and injecting them into the ventricles of developing mouse brains.  Analysis one month 
after birth revealed that the injected cells that had integrated into the endogenous NSC 
niche of the subventricular zone stained for endogenous Dcx. (Figure 2C).  Cells that 
migrated to the cortex could differentiate in vivo and stained for the glial marker GFAP 
or the mature neuron marker NeuN (Figure 2C).  
Since these cells grew like NSCs, expressed the transcripts and proteins 
associated with NSCs, and could differentiate into neurons and glia both in vitro and in 
vivo, they were designated as “induced neural stem cells”, or iNSCs. 
 
iNSC induction from E14.5 MEFs 
We wanted to determine if a similar culture protocol could be used to generate 
iNSCs from later stage MEFs.  To that end, fibroblasts were isolated from E14.5 
embryos after removal of the neural tissue.  The three factors that were detrimental 
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Figure 2. iNSCs differentiate into neurons and glia in vitro and in vivo 
 
(A) Immunostaining for the early differentiation marker doublecortin (Dcx) shortly after 
growth factor withdrawal. (B) Immunostaining for neuronal marker "-III tubulin (TuJ1) in 
cells differentiated with forskolin (top), and immunostaining for glial marker glial fibrillary 
acidic protein (GFAP) in cells differentiated with 1% serum (bottom).  (C) iNSCs labeled 
with FUW-tdTomato were transplanted into the ventricles of E14.5 mouse brains and 
immunostained for differentiation markers one month after birth.  iNSCs and 
endogenous cells in the lateral ventricle/ subventricular zone (LV/SVZ) were 
immunostained for Dcx (top), and cells in the cortex were immunostained for 
differentiation markers GFAP (middle) and neuron-specific neuronal nuclei (NeuN) 
(bottom). 
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Figure S4. Co-generation of neurons and glia 
 
GFAP (red) and TuJ1 (green) immunostaining in cells differentiated by growth factor 
withdrawal.  Dapi (blue) is shown for reference. 
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for iNSC formation (Olig1, Olig2, and Ngn2) were omitted from future transductions; 
however, the Notch effectors Hes3 and Hes5 as well as Sox9 were included in the new 
library of factors.  
Parallel transductions of this new pool of factors into MEFs resulted in multiple 
iNSC lines with morphologies and Sox2-GFP expression similar to primary NSCs 
(Figure 3A and Figure 1D).  RT-PCR analysis revealed that these iNSC lines expressed 
the endogenous NSC genes Sox1, Sox3, Pax6, Blbp, and Brn1 (Figure 3B).  When 
measured quantitatively by qPCR, the transcript expression in iNSC cell lines was 
similar to primary NSCs and distinct from MEFs—iNSCs expressed NSC gene Sox1, 
Sox2, and Pax6, but not fibroblast-specific gene Col5a2 (Figure 3C).  Importantly, upon 
growth factor withdrawal, these cell lines differentiated and stained for TuJ1 and GFAP 
(Figure 3D). 
 
iNSCs can be generated with 7 or 8 factors 
To determine which factors were responsible for generating iNSC lines, we 
developed a PCR strategy to detect the viral transgenes that had integrated in the 
genome of characterized iNSC lines.  We used primers that either spanned introns or, 
for single-exon genes, amplified between the TetO lentiviral promoter and the gene of 
interest. PCR analysis revealed that many different lenti-proviruses had integrated into 
the genome of the iNSC lines, ranging in number from 13 different factors in iNSC5 to  
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Figure 3. Characterization of multiple iNSC lines induced from E14.5 MEFs 
 
(A) Morphology and GFP fluorescence of iNSCs generated from transduced E14.5 
MEFs.  Compare to MEFs shown in Figure 1D.  (B) Non-quantitative (RT)-PCR analysis 
of NSC transcript expression in iNSC lines and uninfected MEFs.  (C) Quantitative PCR 
(qPCR) analysis of indicated NSC and MEF transcripts in MEFs, primary cortical NSCs 
(1! NSC), and iNSC lines. Expression values were normalized to Gapdh expression for 
each cell type. (D) Immunostaining of differentiation markers GFAP and TuJ1 after 
growth factor withdrawal. 
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21 in iNSC2 (Figure 4A).  The high number of integrated factors in these lines may 
reflect a requirement for many different factors to impart stable NSC-like characteristics 
on MEFs, or it may be due to heterogenous cultures made up of multiple cell lines. 
To narrow down the factors, we focused on iNSC5 because it had the fewest 
number of integrated factors, suggesting that some combination of these factors was 
sufficient for generating iNSCs.  We therefore infected E14.5 MEFs with the 13 factors 
present in iNSC5—Sox2, Hes1, Hes3, Brn2, Klf4, Rfx4, Zic1, DN-REST, NICD, Lhx2, 
PLAGL1, Myc, and Bmi1—or with the 13 factors plus FoxG1, which was recently 
reported to be important for creating dox-dependent iNSCs (Lujan et al., 2012).  A time 
course was performed with dox induction periods ranging from 3 to 30 days to 
determine the duration of exogenous factor induction sufficient for iNSC formation 
(Figure 4B).  iNSCs were generated from both lentiviral pools (13 factors and 14 
factors), but only after 30 days on dox (Figure 4B).  The resulting cells lines (iNSC-13F 
and iNSC-14F) had morphologies and GFP expression patterns similar to those of the 
previously characterized iNSC lines and primary NSCs (Figure 4C and 4D).  After 3 
weeks of culture in NSC growth medium, these populations formed stable cell lines and 
homogenously expressed Sox2-GFP in more than 90% of cells (Figure 4D).  
Additionally, the cells expressed NSC marker genes Pou3f3 (Brn1) and Sox2 by qPCR, 
but did not express the MEF genes Col5a2 or Thy1 (Figure 4E).  Like previous iNSC 
lines and primary NSCs, the cells were competent for neuronal and glial differentiation 
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Figure 4. Transgene-independent iNSCs can be induced by 7 or 8 factors 
 
(A) Schematic showing the PCR strategy to detect transduced factors in the genomic 
DNA of iNSC lines (top). Primer sets used either included an universal primer 
recognizing the TetO promoter and a factor-specific reverse primer, or two factor-
specific primers separated by at least one intron in the endogenous gene.  Bottom, PCR 
genotyping results for the transduced factors detected in iNSC lines.  The * denotes line 
iNSC5, which had the fewest number of transduced factors.  (B) Time course with 
varying durations of dox induction.  MEFs were transduced with the 13 factors present 
in iNSC5 (13F) or with the 13 factors plus FoxG1 (14F) and grown in the presence of 
dox for the indicated lengths of time.  iNSCs were not generated at time points earlier 
than 30 days.  (C-D) Morphology and GFP expression of iNSC-13F (13F) and iNSC-14F 
(14F).  The mTomato channel was used to control for autofluorescence.  (E) qPCR 
analysis of NSC and MEF transcript expression in iNSC-13F, iNSC-14F, MEFs, and 
primary cortical NSCs (1! NSC).  (F-G) Immunostaining for differentiation markers GFAP 
and TuJ1 (F) and GFAP and Map2 (G) in iNSC-13F and iNSC-14F cultures after growth 
factor withdrawal.  (H) PCR analysis to detect factors integrated in iNSC-13F and iNSC-
14F genomic DNA.  (I) Southern blot analysis of uninfected MEFs, iNSC-13F, iNSC-14F 
using a Klf4 probe to determine the independence of these two lines.  The * indicates 
endogenous gene. 
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upon growth factor withdrawal (Figure 4F). 
We next determined which transgenes had integrated into iNSC-13F and iNSC-
14F.  We found that 7 factors had integrated into iNSC-13F and 8 factors into iNSC-14F 
(Figure 4G).  Interestingly, these lines shared 6 factors in common: Brn2, Hes3, Klf4, 
Myc, PLAGL1, and Rfx4, with the additional factors being DN-REST in iNSC-13F and 
NICD and Hes1 in iNSC-14F (Figure 4G).  Furthermore, we confirmed the absence of 
FoxG1 integration as well as independence of the cell lines by Southern blot analysis of 
FoxG1 and Klf4, respectively (Figure 4I and data not shown). 
 
Genomic reprogramming of iNSCs 
We next compared the genome-wide gene expression patterns of iNSC-13F and 
iNSC-14F, the starting MEF population, and primary cortical NSCs derived from the 
same genetic background (Sox2-GFP+, rtTA+/+).  Microarray analysis revealed that 
iNSCs expressed many genes that are commonly transcribed in NSCs but have 
silenced MEF-specific marker genes (Figure 5A).  When analyzed for genes 
differentially expressed between published MEF and ES-derived neural precursor cell 
(NPC) datasets (Mikkelsen et al., 2008), iNSCs showed a global gene expression 
pattern similar to the NPCs and primary NSCs (Figure 5B).  Moreover, when the gene 
expression pattern of iNSCs was compared to that of diverse tissue types, such as ES 
cells, ES-derived NPCs, mature neural cell lineages, and MEFs, hierarchical clustering 
showed that iNSCs clustered with primary NSCs and ES-derived NPCs and were 
distinct from fibroblasts and the other cell types (Figure 5C).
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Figure 5. Genome-wide expression analysis of iNSCs 
 
(A) Microarray analysis was performed on the untransduced MEF starting population 
(MEF), primary cortical NSCs (NSC), iNSC-13F, and iNSC-14F.  Shown is the 
normalized expression values at NSC expressed genes and fibroblast expressed genes. 
(B) Differentially expressed genes were determine by analysis of published ES-derived 
NPC (NPC) and MEF datasets (See methods).  The MEF expression level was set to 0.  
NSC is primary NSC from the same genetic background as iNSC-13F and iNSC-14F. 
(C) Expression profiles of iNSC-13F and iNSC-14F were compared to ES cells, ES-
derived NPCs, mature neural cell lineages, and MEFs.  The datasets were analyzed by 
hierarchical clustering and Pearson correlation analysis. 
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Enhancers are chromatin sites where transcription factors, chromatin remodelers, 
histone modifiers, and mediators of the transcriptional machinery bind to control the cell 
type-specific expression of nearby genes (Buecker and Wysocka, 2012; Calo and 
Wysocka, 2013).  Active enhancers, or enhancers that are associated with active 
genes, are marked by histone H3 lysine K27 acetylation (H3K27ac), which displays a 
unique cell type-specific profile (Creyghton et al., 2010; Rada-Iglesias et al., 2011).  The 
dynamic nature of enhancers and their cell type-specificity make them stringent markers 
of cell identity.  To determine if iNSCs reprogrammed their epigenome and had 
enhancer usage similar to primary NSCs, we analyzed H3K27ac genome-wide by 
chromatin immunoprecipitation, followed by massively parallel DNA sequencing (ChIP-
seq).  iNSC-13F had a similar H3K27ac profile as primary NSCs at key NSC loci like 
Olig1/Olig2 and was not marked at a fibroblast-expressed collagen locus (Figures 6A).  
Genome-wide, iNSC-13F had an active enhancer profile that was similar to primary 
NSCs and distinct from the starting population of MEFs (Figure 6B).  Although the vast 
majority of the iNSC-13F genome was reprogrammed to the NSC-like state, there were 
rare sites that displayed a MEF-like H3K27ac pattern (Figure S5), suggesting that 
epigenetic memory of the MEF starting population may persist in these iNSCs. 
Overall, these genome-wide analyses indicated that iNSCs had transcriptionally 
and epigenetically reprogrammed their nucleus to a state that was highly similar to 
primary NSCs, although a few rare genes may indicate residual epigenetic memory from 
their non-neural origin.
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Figure S5. iNSC genes with MEF epigenetic enhancer profile 
H3K27ac profiles for 3 gene that display the MEF enhancer marks: FoxG1 (left), Sox1 
(middle), and Twist1 (right). 
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A genetically homogenous system reproducibly converts MEFs to iNSCs 
We next wanted to test the reproducibility of these factors for generating iNSCs.  
To avoid the inherent complications from factor transduction—such as variation in 
transduction efficiency, heterogenous integration patterns, etc.—we developed a 
"secondary! iNSC reprogramming system based on a similar technology for mouse iPS 
reprogramming because it does not require additional factor transduction (Wernig et al., 
2008b).  First, we generated iPS cells from iNSCs that were transcriptionally, 
epigenetically, and functionally similar to primary NSCs (Figure 7A).  Since the 
integrated neural induction factors were dox-inducible, we transduced iPS-
reprogramming factors with Moloney retroviral vectors, which are permanently silenced 
in pluripotent cells (Jahner et al., 1982) and would not interfere with secondary iNSC 
formation. The iPS cells were pluripotent and formed differentiated teratomas with cells 
of all three germ layers (Figure 7B). Furthermore, when injected into developing 
blastocysts, the cells were able to contribute to chimeras, as shown by the patchy 
expression of the Sox2-GFP reporter in the brain and the spinal cord (Figure 7C). 
To test the ability of these cells to reprogram into iNSCs, MEFs were isolated 
from E14.5 chimeras after removing the neural tissue and selecting with puromycin.  
These fibroblasts were genetically homogenous and contained the transduced neural 
factors in the exact stochiometry and proviral integration sites that were sufficient to 
produce the original (“primary”) iNSC line.  Upon dox addition, the cells proliferated 
more rapidly and underwent morphological changes that were not observed in  
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uninduced cells.  Using the same protocol as before, Sox2-GFP+ “secondary” iNSC 
lines could be generated, and after one passage these cells had similar morphology, 
growth properties, and Sox2-GFP expression patterns as embryonic NSCs and the 
original iNSC line (Figure 7D).  The two iPS clones tested were both able to generate 
multiple independent secondary iNSC lines that differentiated into neurons and glia 
upon growth factor withdrawal (Figure 7E).  Thus, the secondary system showed that 8 
transcription factors are sufficient to generate iNSCs from embryonic fibroblasts. 
 
DISCUSSION 
!
 Reprogramming somatic cells to pluripotency by overexpressing defined factors 
is a well-established phenomenon; however, it is unknown whether a non-pluripotent 
cell type can be induced from somatic cells in a similar manner, or whether a 
reprogrammed non-pluripotent nucleus can be maintained in the absence of transgenic 
factor overexpression (Hanna et al., 2010; Jaenisch and Young, 2008).  Here we have 
shown that the forced expression of defined factors can generate neural stem-like cells 
(iNSCs) from MEF cultures.  Importantly, when analyzed in the absence of exogenous 
factor overexpression, these cells exhibit many features of endogenous NSCs including 
morphology, growth properties, and capability to differentiate into neurons and glia, as 
well as genome-wide transcriptional and epigenetic patterns.   
The use of dox-inducible lentiviral vectors for factor induction (Brambrink, 2008) 
allows iNSCs to be maintained in the absence of exogenous factor overexpression.  
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This is important because naturally occurring cell states are stable, and a cell that has 
been truly converted would be equally stable and would not require exogenous 
perturbations to maintain its properties.  Furthermore, expressed transgenes may 
contribute to the reprogrammed cells! phenotypes and mask their inherent properties, 
thus making it difficult to determine the cells! true identity, or whether the endogenous 
circuitry is fully activated.  
The stable iNSCs generated in this study show a transcriptionally and 
epigenetically reprogrammed genome.  Our genome-wide epigenetic analysis shows 
that iNSCs maintain NSC-specific active enhancers in the absence of exogenous factor 
induction.  This indicates that they have activated the endogenous regulatory circuitry 
responsible for maintaining the NSC cell state.  To our knowledge, this stringent 
assessment of cell type-specific epigenetic identity has not been reported for “induced” 
somatic cells.  Furthermore, the activation and stabilization of a somatic cell!s 
endogenous regulatory network have not been conclusively shown prior to these 
experiments.  In the previous studies, the maintenance of the iNSC state was 
dependent on continuous transgene expression from either constitutive or inducible 
vectors (Han et al., 2012, Ring et al., 2012; Lujan et al., 2011; Najm et al., 2013; Ying et 
al., 2013).   
Despite being induced by slightly different sets of factors, the dox-independent 
iNSC lines generated in this study are highly similar to one another.  For instance, the 
cell lines have similar qPCR gene expression patterns, morphology, and bipotent 
differentiation potentials.  This may be due to the highly redundant sets of transcription 
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factors responsible for each cell line—all cell lines share a core set of 6 transcription 
factors: Brn2, Hes3, Klf4, Myc, PLAGL1, and Rfx4—that may promote the induction of 
these characteristics.  Alternatively, the defined growth conditions may select for this 
specific type of NSC. 
Although the minimal factors necessary for iNSC formation have not been 
determined, the secondary system has shown that 8 factors—the 6 core factors plus 
Hes1 and Notch (NICD)—are efficient in reproducibly inducing iNSC formation.  The 
finding that a core set of 6 transcription factors is present in all iNSC lines suggests that 
these factors are important for transgene-independent iNSC induction.  Most of the core 
factors are not well-studied in NSCs so their roles during this reprogramming process 
are obscure, but they may represent key genes for understanding NSC biology.  For 
instance, recently it was shown that forced expression of Brn2 in ES cells functionally 
recruits Sox2 to certain NSC enhancers (Lodato et al., 2013).  Although Sox2 has not 
been transduced in most iNSC lines, Brn2 may serve a similar recruitment role with one 
of the other exogenous factors, such as Rfx4, which also binds at active NSC 
enhancers (Creyghton et al., 2010).  Hes3 is a Notch effector gene and has been shown 
to be important for NSC maintenance (Imayoshi et al., 2010).  It remains to be 
determined if there is a functional difference between Hes1, Hes3, and Hes5 that 
explains why Hes3 is transduced in all iNSC lines and the other genes are not, since 
they have previously been shown to be functionally redundant (Imayoshi et al., 2010).  
PLAGL1 function has not been studied in NSCs, but it was found to have the highest 
level of differential expression between rosette NSCs and EGF/FGF responsive NSCs 
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(Elkabetz, et al., 2008).  Myc and Klf4 are both expressed in NSCs, but their role in 
iNSC formation may be a more general reprogramming effect, since they are also 
important for iPS formation. 
The secondary system for iPS cells has provided a wealth of information about 
the iPS reprogramming process, as well as the molecular players important for 
reprogramming in vitro and in vivo (Wernig et al., 2008c; Hanna et al., 2009; Buganim et 
al., 2012b; Mansour et al., 2012). The secondary reprogramming system for iNSC 
formation may be a similarly useful tool for studying the NSC-like state.  The system will 
allow for many unresolved issues of iNSC formation to be addressed, such as the 
efficiency of reprogramming and the duration of factor induction required for full 
epigenetic reprogramming.  It also provides an unlimited supply of different cell types 
that are genetically competent for iNSC formation that can be used to dissect the 
molecular determinants of this reprogramming process, screen for genes or chemicals 
that accelerate this iNSC formation, and find factors that facilitate complete epigenetic 
reprogramming eliminating epigenetic memory. 
The results presented in this study demonstrate that embryonic fibroblasts can 
be epigenetically reprogrammed into neural stem-like cells.  However, whether adult 
cells can be similarly converted is currently not known. Many adult cell types are more 
difficult to transduce than MEFs, but they are efficiently reprogrammed to iPS cells using 
the iPS-secondary system (Hanna et al., 2008; Wernig et al., 2008b).  Our iNSC-
secondary system provides an optimal tool for studying adult cell conversion.  It would 
be interesting to determine if iNSCs can be induced from adult cells and if forced 
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expression of factors can epigenetically convert, or “transdifferentiate,” cells derived 
from other germ layers such as endoderm cells. 
!
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EXPERIMENTAL PROCEDURES  
 
Mouse embryonic fibroblast (MEF) isolation 
MEFs were isolated from E14.5 embryos that contained two alleles of the M2 
reverse tetracycline trans-activator (M2rtTA) in the constitutively active Rosa26 locus 
(Rosa26-rtTA +/+) (Beard et al., 2006).  The embryos also harbored one allele of Sox2-
GFP in which the endogenous Sox2 gene was replaced by a sequence encoding eGFP 
(Ellis et al., 2004).  After removing the head, vertebral column, and internal organs, 
MEFs were dissociated in 0.25% trypsin (Sigma) for 10 minutes, split onto two 15-cm 
plates, and grown in MEF medium [DMEM supplemented with 10% FBS (Hyclone), 
penicillin and streptomycin (100 µg/ml) (Life Technologies), L-glutamine (2mM) (Life 
Technologies), and nonessential amino acids (Life Technologies)] until confluent and 
then frozen.  MEFs passaged one to two times were used for transduction experiments. 
MEFs in the secondary iNSC reprogramming experiments were isolated from E14.5 
chimeras using the same protocol as above except that chimeria cells were selected in 
medium containing puromycin for 4-6 days. 
 
Lentiviral cloning and infections 
To create lentiviral factors, genes of interest were amplified by PCR either from 
cDNA libraries or from cDNA expression vectors using primers flanked by EcoRI 
restriction sites (MfeI was used instead of EcoRI for genes that contained internal EcoRI 
restriction sites).  The PCR products were cloned into the TOPO-TA cloning vector (Life 
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Technologies) following the manufacturer!s instructions.  The genes were then excised 
from the TOPO-TA vector and ligated into the EcoRI site of the FUW-TetO lentiviral 
backbone in which transgene expression is controlled by the tetracycline-reponsive 
operator sequence and a minimal CMV promoter (TetO) (Beard et al., 2006).   
Lentivirus was generated in 6-well plates by co-transfecting 293T cells with 2.5 
µg of lentiviral vector, 0.625 µg of pMD2.G, and 1.875 µg psPAX2 (packaging vectors 
from Addgene) using Fugene 6 (Promega) according to the manufacturer!s instructions. 
MEF medium was replaced 16-24 hours after transfection.  Viral supernatants were 
harvested 48 and 72 hours after transfection and filtered through a 0.45 µm filter.  MEFs 
were transduced by adding a 1:1 mixture of viral supernatants and MEF medium to the 
cells in the presence of 8 µg/ml polybrene (Sigma).  After 24 hours, the MEF medium 
was replaced and on the following day doxycycline (Sigma) was added (2 ug/ml). 
 
Neural cell culture 
Primary neural stem cells and established iNSCs were cultured in N2 medium 
(Okabe et al., 1996) [DMEM/F-12 medium containing insulin (5 µg/ml) (Sigma), 
transferrin (100 µg/ml) (Sigma), sodium selenite (30 nM) (Sigma), progesterone (20 nM) 
(Sigma), putrescine (100 nM) (Sigma), and penicillin and streptomycin (100 µg/ml) (Life 
Technologies)] supplemented with 20 ng/ml epidermal growth factor (EGF) (R & D 
systems), 20 ng/ml basic fibroblast growth factor (bFGF) (Sigma), and laminin (1 µg/ml) 
(Life Technologies).  Medium was replenished every 24-48 hours, and cells were 
passaged every 2-3 days.  Typically, cells were differentiated by EGF withdrawal for 2 
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days followed by complete growth factor withdrawal for 4-6 additional days.  Directed 
differentiations were performed by withdrawing EGF and bFGF and supplementing N2 
medium with 5 µM forskolin (Stemgent) for neuronal differentiation or with 1% FBS for 
glial differentiation.  
 
Primary neurosphere and cortical NSC derivation 
Neurospheres were isolated from the subventricular zone of E12.5 embryos 
essentially as described previously (Doetsch et al., 1999).  Briefly, subventricular zone 
tissue was collected in Pipes buffer [20 mM Pipes, 25 mM glucose, 0.12 M NaCl, and 
0.5 mM KCl] and digested with activated papain (Sigma).  After 1 hr at 37°, cells were 
triturated, centrifuged, and resuspended in the presence of ovomucoid (Sigma) and 
DNase (Qiagen).  Cells were purified by Percoll gradient centrifugation and plated on 
non-adherent plastic dishes in N2 medium supplemented with 20 ng/ml EGF and 20 
ng/ml bFGF. 
For Cortical NSCs, the forebrain cortex of E12.5 embryos was collected in Hank!s 
buffered saline solution (HBSS).  Tissue was dissociated by tritruation and then 
incubated in HBSS for 10 minutes at room temperature.  Cells were collected by 
centrifugation and plated in N2 containing EGF (20 ng/ml), FGF (20 ng/ml), and laminin 
(1 ug/ml). 
 
iNSC reprogramming 
For the generation of iNSCs, transduced MEFs were grown for 4 days in MEF 
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medium supplemented with 2 µg/ml doxycycline (Sigma) before being switched to 
neural induction medium [N2 medium plus 10ng/ml EGF, 10ng/ml FGF (Sigma), 1 µg/ml 
laminin, and 2 µg/ml doxycycline].  The cells were grown in neural induction medium for 
2-3 weeks before the addition of neural selection medium, which is also called ITSFn 
[DMEM/F-12 medium containing insulin (25 µg/ml), transferrin (50 µg/ml), sodium 
selenite (30 nM), fibronectin (5 µg/ml) (Sigma), and penicillin and streptomycin (100 
µg/ml)] (Okabe et al., 1996).  The selection medium was supplemented with doxycycline 
(2 µg/ml) for the first 4 days, and on day 10 the cultures were dissociated by incubating 
them with 0.25% trypsin (Sigma) for 5-10 minutes.  The trypsin was quenched with 10% 
serum (Hyclone), and the cells were collected by centrifugation and washed once with 
DMEM/F-12.  The cells were then replated onto plates coated with polyornithine (15 
µg/ml) (Sigma) for 24 hours and then laminin (1 µg/ml) for an additional 24 hours and 
then grown in neural expansion medium [N2 supplemented with 20 ng/ml EGF, 20 ng/ml 
bFGF, and 1 µg/ml laminin].  Medium was replenished every other day for 2-3 weeks 
until NSC-like foci became visible, after which cells were fed daily to promote the growth 
of NSC-like cells.  Sox2-GFP+ cells were sorted directly into polyornithine and laminin 
coated plates using the BD FACSAria IIU cell sorter (BD Biosciences). 
 
RT-PCR  
RNA was purified using the Trizol reagent (Life Technologies) according to the 
manufacturer!s instructions, treated with DNase (Qiagen), and reverse transcribed using 
Superscript III (Life Technologies).  Quantitative PCR was performed using SYBR-
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Green master mix (Life Technologies) and analyzed on the ABI 7900 machine.  Non-
quantitative and quantitative PCR primer sequences are listed in Tables S3 and S4). 
  
Immunostaining 
For NSC and iNSC immunostaining, cells were washed twice with HBS, fixed in 
4% paraformaldehyde for 20 minutes at room temperature, and then washed twice in 
PBS containing magnesium and calcium ions (PBS+).  Cells were blocked by incubating 
them in PBS+ containing 5% normal donkey serum (Jackson Immunoresearch) and 
0.3% Triton X-100 (Sigma) for 60 minutes at room temperature.  Antibodies were diluted 
in a solution of PBS+ with 1% BSA (Sigma) and 0.3% Triton X-100.  Primary antibodies 
were incubated overnight at 4°, and secondary antibodies were incubated for 60 
minutes at room temperature in the dark.  Cells were washed 3 times with PBS+ after 
the primary antibody incubation and twice after secondary antibody incubation.  For 
staining nuclei, cells were incubated with 4',6-diamidino-2-phenylindole (DAPI) for 5-10 
minutes and subsequently washed with PBS+.  The following antibodies were used:  
mouse anti-Nestin (Developmental Studies Hybridoma Bank (DSHB), 1:500), rabbit anti-
Sox1 (Cell Signaling, 1:500), goat anti-Sox2 (R&D systems, 1:500), goat anti-
Doublecortin C-18 (Santa Cruz, 1:500), rabbit anti-GFAP (DAKO, 1:1000), and mouse 
anti-Tuj1 (Covance, 1:1000). 
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Transplantation assay 
Transplantation assays were performed essentially as described (Wernig et al., 2008c; 
Brustle et al., 1997).  Briefly, iNSCs were dissociated in 0.25% trypsin (Sigma) for 3 
minutes and quenched with 10% serum (Hyclone) in DMEMF-12.  Cells were collected 
and washed twice with DMEM/F-12.  Cells were resuspended at a concentration of 
100,000 cells/µl in N2 medium.  1 µl of cells was injected into the lateral ventricle of 
E14.5 stage Balb/c embryos.  Cell integration was measured one month after birth by 
performing a 4% paraformaldhyde perfusion followed by overnight postfix in preparation 
for floating section analysis.  Sections with iNSC-specific FUW-tdTomato expression 
were analyzed with the following antibodies:  goat anti-Doublecortin C-18 (Santa Cruz, 
1:500), mouse anti-NeuN (Millipore, 1:100), and rabbit anti-GFAP (DAKO, 1:1000). 
 
iPS reprogramming 
The pMXs Moloney viruses Oct4, Klf4, Myc, Nanog, and Sall4 were purchased from 
Addgene (Takahashi and Yamanaka, 2006).  pMXs-Esrrb was generated by digesting 
TetO-Esrrb (Buganim et al., 2012) with EcoRI  and then ligating it into the EcoRI site of 
pMXs.  To reprogram iNSCs to pluripotentcy, equal amounts of pCLeco and either Oct4, 
Klf4, Myc, Nanog, Sall4, or Esrrb lentiviral plasmids were co-transfected into 293T cells 
using the Fugene 6 transfection reagent (Promega).  One day after transfection, the 
293T culture medium was exchanged for N2 supplemented with 20 ng/ml EGF, 20 
ng/ml bFGF, 1 µg/ml laminin, and 5 µg/ml fibronectin.  Viral supernatants were collected 
48 and 72 hours after transfection and pooled for infection.   
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The infected cells were grown in NSC medium for 4 days and then grown in ES 
medium [DMEM supplemented with 10% FBS (Hyclone), penicillin and streptomycin 
(100 µg/ml) (Life Technologies), L-glutamine (2mM) (Life Technologies), nonessential 
amino acids (Life Technologies), 0.1 mM #-mercaptoethanol, and leukemia inhibitory 
factor (Lif)].  When pre-iPS colonies began to emerge, the culture was switched to 
serum-free 2i/Lif medium [1:1 mixture of DMEM/F-12 (Life Technologies) and 
Neurobasal (Life Technologies) base mediums plus N2 supplement (Life Technologies), 
B27 supplement (Life Technologies), recombinant human LIF, 2 mM L-glutamine (Life 
Technologies), 1% nonessential amino acids (Life Technologies), 0.1 mM #-
mercaptoethanol (Sigma), penicillin and streptomycin  (100 µg/ml) (Life Technologies), 5 
µg/mL BSA (Sigma), 1 µM PD0325901 (Stemgent), and 3 µM CHIR99021 (Stemgent)] 
(Hanna et al., 2010).  iPS colonies were manually picked and after 1 passage in 2i/lif 
medium, they were cultured in ES medium. 
 
Teratomas and blastocyst injections 
For teratoma analysis, cells were dissociated in 0.25% trypsin and then collected 
in ES medium.  5 x 105 cells were injected subcutaneously into both flanks of recipient 
immunocomprimised SCID mice (Brambrink et al., 2008).  Tumors approximately 1 cm 
in diameter were harvested 3-4 weeks after injection for paraffin sectioning and stained 
with hematoxylin and eosin.  Blastocyst injections were performed as described (Wernig 
et al., 2008b) except that E14.5 embryos were extracted from pregnant females 12 days 
after blastocyst injection for the isolation of MEFs. 
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[Computational Methods Provided by ZFP] 
 
Identifying ChIP-Seq enriched regions  
The MACS version 1.4.1 (Model-based analysis of ChIP-Seq) (Zhang et al., 
2008) peak finding algorithm was used to identify regions of ChIP-Seq enrichment over 
background. A p-value threshold of enrichment of 1 X 10-9 was used for all data sets. 
 
Defining active enhancers! 
Active enhancers were defined as regions of enrichment for H3K27ac outside of 
promoters (greater than 5 kb away from any transcriptional start site (TSS)). H3K27ac is 
a histone modification associated with active enhancers (Creyghton et al., 2010; Rada-
Iglesias et al., 2011).  
 
ChIP-Seq density heatmaps and composite ChIP-Seq density profiles 
In order to display ChIP-Seq levels at enhancers, a heatmap representation was 
used. In the heatmap representation, each row represented the ±5 kb centered on the 
center of H3K27ac enriched region. Each 50 bp bin in each row was shaded based on 
intensity of ChIP-Seq occupancy using Java Treeview (http://jtreeview.sourceforge.net/). 
 
Microarray analysis 
All expression profiles including the previous published expression datasets were 
processed together to generate Affymetrix MAS5-normalized probe set values. We 
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processed all CEL files by using the probe definition (“mouse4302 cdf”) and the 
standard MAS5 normalization technique within the affy package in R to get probe set 
expression values.  
The expression profiles were compared and clustered by hierarchical clustering 
using average linkage. The distance matrix was calculated using Pearson correlation 
coefficients of the top 50 percent of probe sets with the largest coefficients of variation 
across expression profiles. 
The differentially expressed probe sets between the published datasets of mouse 
embryonic fibroblasts (MEFs) and mouse neural precursor cells (mNPCs) were 
determined using a linear model within the limma package in R. The empirical Bayes 
approach was used to estimate variances. The differentially expressed probe sets were 
required to have absolute value of log2-fold change greater than 2 and FDR-adjusted p-
value less than 0.01.  
 
Previously published gene expression datasets 
Two previously published datasets using the Affymetrix Mouse Genome 430 2.0 
Array (platform ID GPL1261) microarray platform were obtained from the Gene 
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) database (Supplementary 
Table 5). For Mikkelsen et al. (2007), data were obtained from the GEO database 
accession GSE8024. For Cahoy et al. (2008), data were obtained from the GEO 
database accession GSE15148. 
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Supplementary Table 1. Defined factors screened for iNSC formation in MEFs 
Gene Name Species Genbank Accession 
Ascl1 Mouse NM_008553 
Bmi1 Mouse NM_007552 
Brn2 Mouse NM_008899 
DN-REST (P73 REST) Human NM_005612  (REST) 
Hes1 Mouse NM_008235 
Hes3 Mouse NM_008237 
Hes5 Mouse NM_010419 
Klf4 Mouse NM_010637 
Lhx2 Mouse NM_010710 
MEF2CA Human NM_002397  (MEF2C) 
mir124a Human NR_029668 
c-Myc Mouse NM_010849 
Myt1l Mouse NM_001093775 
Ngn2 Mouse NM_009718 
NOTCH- intracellular 
domain (ICD) 
Human NM_017617 (NOTCH1) 
Olig1 Mouse NM_016968 
Olig2 Mouse NM_016967 
PLAGL1 Human NM_002656 
PLZF Human NM_006006 
Rfx4 Mouse NM_001024918 
Sox1 Mouse NM_009233 
Sox2 Mouse NM_011443 
SOX3 Human NM_005634 
Sox9 Mouse NM_011448 
Zic1 Mouse NM_009573 
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Supplementary Table 2. Primers for PCR genotyping factor integrations 
Gene Name Forward Primer Reverse Primer 
Ascl1 ATCCACGCTGTTTTGACCTC GTTTGCAGCGCATCAGTTC 
Bmi1 GTGTACGGTGGGAGGCCTAT TGCAACTTCTCCTCGGTCTT 
Brn2 GTGTACGGTGGGAGGCCTAT CACCCTGCTGTACCACCAC 
DN-REST GAATCTGGCTCTTCCACTGC GAGGTTTAGGCCCATTGTGA 
Hes1 ATCCACGCTGTTTTGACCTC GTCACCTCGTTCATGCACTC 
Hes3 GTGTACGGTGGGAGGCCTAT AGGCAAGGGTTGAGAACAGA 
Hes5 GTGTACGGTGGGAGGCCTAT CAGGAGTAGCCCTCGCTGTA 
Klf4 GTGTACGGTGGGAGGCCTAT CTAGGTCCAGGAGGTCGTTG 
Lhx2 GCGAATACCCAGCACACTTT TAAAAGGTTGCGCCTGAACT 
MEF2CA CTTATGAGCTGAGCGTGCTG GTGAGCCAGTGGCAATAGGT 
mir124a ATCCACGCTGTTTTGACCTC AATCAAGGTCCGCTGTGAAC 
c-Myc GTGTACGGTGGGAGGCCTAT ACCGCAACATAGGATGGAGA 
Myt1l GTGTACGGTGGGAGGCCTAT CCCCTTGCTCATCATTGTCT 
Ngn2 ATCCACGCTGTTTTGACCTC GTCTTCTTGATGCGCTGCAC 
NOTCH ICD  CATGGACGACAACCAGAATG CATGTTGTCCTGGATGTTGG 
Olig1 ATCCACGCTGTTTTGACCTC GTGGCAATCTTGGAGAGCTT 
Olig2 ATCCACGCTGTTTTGACCTC GGGCTCAGTCATCTGCTTCT 
PLAGL1 CAAGTGTGTGCAGCCTGACT ATCTCTGGGCACAGAACTGG 
PLZF GTGTACGGTGGGAGGCCTAT CTGGATGGTCTCCAGCATCT 
Rfx4 GTTACTGGAGGAACCCGACA GAATATGCCACCGTCTGCTT 
Sox1 GTGTACGGTGGGAGGCCTAT GTCCTTCTTGAGCAGCGTCT 
Sox2 GTGTACGGTGGGAGGCCTAT CTCCGGGAAGCGTGTACTTA 
SOX3 GTGTACGGTGGGAGGCCTAT CTGCGTTCGCACTACTCTTG 
Sox9 AGGAAGCTGGCAGACCAGTA CCCTCTCGCTTCAGATCAAC 
Zic1 TCTGCTTCTGGGAGGAGTGT CTGTTGTGGGAGACACGATG 
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Supplementary Table 3.  Primers used for RT-PCR 
 
 
 
 
Gene Forward Primer Reverse Primer Size 
Gapdh AGGCCGGTGCTGAGTATGTC 
 
TGCCTGCTTCACCACCTTCT 
 
297 
Sox1 AGGGCCCAAGAGTAAGGAAA 
 
TGGGATAAGACCTGGGTGAG 
 
443 
Sox3 CGTAACTGTCGGGGTTTTGT 
 
CACGCACACCTGGCTATAAA 
 
371 
Pax6 GGTCACAGCGGAGTGAATCAGC 
 
AGCCAGGTTGCGAAGAACTCTG 
 
267 
Blbp GAAGGTGGCAAAGTGGTGAT 
 
GGGACTCCAGGAAACCAAGT 
 
307 
Brn1 TCTATGGCAACGTGTTCTCG 
 
CGTCATGCGTTTTTCCTTTT 
 
347 
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Supplementary Table 4. Primers used for qPCR 
 
Gene Forward Primer Reverse Primer 
Col5a2 TAGAGGAAGAAAGGGACAAAAAGG 
 
GTTACAACAGGCACTAATCCTGGTT 
 
Thy1 CGAATCCCATGAGCTCCAAT 
 
CCAGCTTGTCTCTATACACACTGATA 
 
Sox1 TGTAATCCGGGTGTTCCTTC 
 
AACCCCAAGATGCACAACTC 
 
Nestin GCGGTGCGTGACTACCAG 
 
CAGCTGCTGCACCTCTAAGC 
 
Brn1 TCAACAGCCACGACCCTC 
 
GGTGAAACCCAGCTTGATGC 
 
Sox2 ACTTTTGTCCGAGACCGAGA 
 
CTCCGGGAAGCGTGTACTTA 
 
Pax6 GAAGGAGGGGGAGAGAACAC 
 
CTCCAGAGCCTCAATCTGCT 
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Supplementary Table 5. Previously published gene expression datasets used for this 
study 
Cell Type GEO ID Name Reference 
Neural precursor cells GSM198065 ES derived NPC Replicate 1 Mikkelsen et al., 2007 
Neural precursor cells GSM198066 ES derived NPC Replicate 2 Mikkelsen et al., 2007 
Neural precursor cells GSM198067 ES derived NPC Replicate 3 Mikkelsen et al., 2007 
Mouse Embryonic 
Stem Cells 
GSM198062 
Mouse Embryonic Stem Cells 
Replicate 1 
Mikkelsen et al., 2007 
Mouse Embryonic 
Stem Cells 
GSM198063 
Mouse Embryonic Stem Cells 
Replicate 2 
Mikkelsen et al., 2007 
Mouse Embryonic 
Stem Cells 
GSM198064 
Mouse Embryonic Stem Cells 
Replicate 3 
Mikkelsen et al., 2007 
Mouse embryonic 
fibroblasts 
GSM198070 
Mouse embryonic fibroblasts 
Replicate 1 
Mikkelsen et al., 2007 
Mouse embryonic 
fibroblasts 
GSM198072 
Mouse embryonic fibroblasts 
Replicate 2 
Mikkelsen et al., 2007 
Oligodendrocytes GSM241889 Oligodendrocytes Cahoy et al., 2008 
Oligodendrocytes GSM241891 Oligodendrocytes Cahoy et al., 2008 
Oligodendrocytes GSM241892 Oligodendrocytes Cahoy et al., 2008 
Oligodendrocytes GSM241917 Oligodendrocytes Cahoy et al., 2008 
Astrocytes GSM241912 Astrocytes Cahoy et al., 2008 
Astrocytes GSM241914 Astrocytes Cahoy et al., 2008 
Astrocytes GSM241926 Astrocytes Cahoy et al., 2008 
Neurons GSM241904 Neurons Cahoy et al., 2008 
Neurons GSM241896 Neurons Cahoy et al., 2008 
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Conclusions 
The discovery that any cell can be reprogrammed to pluripotency revolutionized 
the way we thought about development: it went from being a rigidly firm, unidirectional 
process to one that can be reversed to pluripotency through the concerted action of 3 or 
4 transcription factors.  However, pluripotency may represent a special cellular state that 
is uniquely capable of being captured in vitro because it has a transcriptional circuitry 
that induces and regulates itself, as well as chromatin regulators that are not expressed 
in somatic cells.  The work presented in this thesis has shown that it is possible to 
generate stable epigenetically reprogrammed somatic cells using transcription factors. 
As mentioned in the introduction, previous studies on the induction of neural 
stem-like cells using transcription factors were inconclusive in demonstrating that the 
resulting cell was truly converted.  First, in those studies transgene expression was not 
turned off, so it is not possible to conclude that the maintenance of the iNSC state was 
independent of the continuous expression of inducing factors. Second, minimal or no 
epigenetic analysis was performed to indicate that the epigenome was reprogrammed to 
the patterns of the endogenous cell.  Third, iNSC formation in these studies was rare 
and not quantitated, making it difficult to assess reprogramming efficiency. 
We have demonstrated here that it is indeed possible to generate a stably 
reprogrammed, transgene-independent NSC epigenetic state.  This was accomplished 
using the dox-inducible transgene expression and then maintaining and characterizing 
the cells after dox withdrawal.  Our finding that many Sox2-GFP+ cells are induced in 
the presence of dox, but few—if any—maintain their GFP expression after dox removal 
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highlights the importance of cell analysis without transgene induction because the 
exogenous factors can have a dramatic effect on the cell!s properties. 
 We performed genome-wide H3K27ac profiling and found that the enhancer 
usage in iNSCs is nearly identical to that of NSCs and distinct from MEFs.  This 
suggests that iNSCs have an epigenetically reprogrammed nucleus.  However, the 
extent of reprogramming is unclear, since a few genes maintained the pattern 
characteristic of MEFs.  It would be interesting to compare these genes to determine if 
they are regulated by a common factor that is necessary for complete epigenetic 
reprogramming. 
 We have shown that iNSC formation is reproducible by generating a "secondary! 
iNSC reprogramming system that allows for iNSC formation without the need for 
additional viral transduction.  Both of the iPS clones used to make fibroblasts were able 
to generate multiple independent secondary iNSC lines.  
The establishment of dox-independent iNSC clones was greatly aided by two 
factors: 1) the selection medium and 2) the proliferative nature of the NSCs.  The 
medium used for selecting iNSCs is also used during in vitro-derivation of NSC from ES 
cells and was empirically found to promote the preferential growth of NSCs (Okabe et 
al., 1996).  Similar to iPS reprogramming, when dox is withdrawn from the 
reprogramming cells, much of the culture dies and only a few clones survive.  Since 
iNSCs proliferate, the rare clones with proper neural properties can grow out and be 
isolated either by manual picking or FACS.  The dox withdrawal and selection medium 
may act cooperatively to ensure that only fully reprogrammed iNSCs survive. 
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Unresolved issues 
 One unresolved issue from this study is the minimum group of factors necessary 
to generate stable iNSCs.  The identity of these factors may hint at the critical regulators 
of NSC biology, since these factors are able to induce and stabilize the NSC phenotype.  
It is interesting, however, that 3 Notch family members (Notch-ICD, Hes1, and Hes3) 
are among the 9 factors found in the iNSCs (iNSC-13F and iNSC-14F).  This supports 
the finding that Notch signaling is important for NSC maintenance (Kageyama et al., 
2009; Imayoshi et al., 2010).  The reproducibility of reprogramming using the secondary 
system will allow for optimizing growth conditions for efficient iNSC formation, which 
could aid the screening of factors necessary for generating iNSCs. 
 A second unresolved issue is whether iNSCs are de novo induced rather than 
selected from a pre-existing cell such as a neural crest-derived cell present in the 
starting population.  Since cells are cultured long-term for iNSC reprogramming, a rare 
somatic cell—like a somatic progenitor cell—could be selected by the culture conditions 
and be scored as a “reprogrammed” cell.  Generating iNSCs from an adult starting 
population would resolve these issues.  The most stringent criteria for reprogramming 
would be a genetic marker such as the rearrangement of the TCR or Ig locus in T- or B-
cells. 
 A third unresolved issue is whether iNSC formation transiently passes through a 
pluripotent state during the numerous cell divisions required for the process.  This is a 
concern because the ITSFn medium used for iNSC selection is also used to differentiate 
ES cells to NSCs in vitro.  However, no ES-specific factors are used for iNSC 
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reprogramming, so it is unclear how pluripotency would be achieved.  One way to 
determine if iNSC formation passes through pluripotency is to make iNSCs in a genetic 
background that includes both a Cre driven by the endogenous Oct4 promoter and a 
lox-stop-lox GFP allele.  If the endogenous Oct4 gene is activated, Cre will genetically 
mark the cells and GFP will be expressed. 
 A fourth unresolved issue is the extent of transgene independence.  The dox-
inducible (Tet-On) system used for inducing exogenous factor expression is known to 
allow for low levels of residual transgene expression, which may alter the cells! 
molecular characteristics (Soldner et al., 2009).  However, since the residual expression 
does not interfere with the differentiation of iNSCs or their reprogramming to 
pluripotency, it is unlikely that the basal expression of the neural factors is enough to 
maintain NSC characteristics.  One way to stringently demonstrate transgene-
independence is to create iNSCs using excisable vectors, like lentiviruses with LoxP 
sites in the LTRs.  Then the exogenous factors can be physically removed from the 
genome after Cre-mediated recombination, and the molecular features of the iNSCs can 
be assessed in the absence of any viral reprogramming factors.  
 
Outlook: towards transdifferentiation 
In the most strict definition, transdifferentiation is the conversion of one somatic 
cell state directly into a distinctly different somatic cell state without passing through a 
pluripotent intermediate (Wagers and Weissman, 2004; Graf and Enver, 2009; Hanna et 
al., 2010).  Although iNSCs have been generated from MEFs, this study does not fulfill 
 141!
these criteria for two reasons.  First, the starting cell is a heterogenous mix of embryonic 
cells.  Although the CNS tissue is removed, there is no way to retrospectively determine 
the origin of the starting cell.  Second, we cannot rule out the possibility that the 
conversion event may have gone through a pluripotent intermediate.  Thus, using the 
secondary system described in this thesis, the most stringent criteria for 
transdifferentiation would include: 
1. Excluding a pluripotent intermediate step by deleting Oct4 in the somatic cell.  
The secondary cells come from a background with both alleles of Oct4 floxed 
(Pou5f1flox/flox), such that the endogenous Oct4 allele is knocked out upon Cre 
administration and therefore pluripotency cannot be achieved (Nichols et al., 1998).  
2. The use of a genetic marker to retrospectively identify the donor cell.  This 
could be accomplished by reprogramming B- or T-cells carrying VDJ or TCR 
rearrangements, respectively.  Alternatively, the iPS cells could be targeted with a cell 
type-specific Cre, like Albumin-Cre (marking hepatocytes) or Mx1-Cre (marking blood 
cells), which would genetically alter the Oct4 alleles specifically in the cell types that 
express the gene. 
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In summary, factor-mediated reprogramming demonstrates that forced 
expression of transcription factors can induce pluripotency on a differentiated cell.  The 
work in this thesis shows that the effect of transcription factors is not simply restricted to 
inducing pluripotency, but can also induce and stabilize somatic cell types.  
Furthermore, the tools and techniques presented here may be applicable to future 
investigations aiming to accomplish cross-lineage transdifferentiation. 
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